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I. INTRODUCTION 
Organophosphorus pesticides are widely used in veter-
inary medicine as systemic and nonsystemic insecticides. 
Many factors may potentiate or enhance organophosphorus 
pesticides toxicity in mammals. The concurrent usage of 
more than one organophosphate (DuBois, 1961), and stress 
factors such as malnutrition or low dietary protein (Kahn, 
1973; Gopal et al., 1976), and disease conditions (Khan, 
1973) are important potentiators. Of particular interest 
is the iatrogenic effect of phenothiazine tranquilizers in 
organophosphate toxicity in several species such as man 
(Arterberry et al., 1962), rat (Gaines, 1962), and sheep 
(Gopal et al., 1976). 
Based on phenothiazine tranquilizer data, the use of 
organophosphates in conjunction with phenothiazine anthel-
mintic is contraindicated in veterinary medicine because 
of possible potentiation of toxicity (Maddy and Riddle, 
1977). This type of potentiation, if it exists, is impor-
tant because it is not uncommon in veterinary medicine to 
use ectoparasiticides and endoparasiticides concurrently, 
and also because of the renewed interest in the usage and 
effectiveness of phenothiazine anthelmintic against sheep 
nematodes resistant to thiabendazole, levamisole, or 
morantel tartrate (Kelly et al., 198la, b). 
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This study was undertaken to examine the extent of 
cholinesterase inhibition and clinical effects of repeated 
topical application of the organophosphorus insecticide 
(Ciovap®) and the oral administration of phenothiazine 
anthelmintic either alone or in combination in sheep with 
or without the added stress of clinical infection with 
gastrointestinal p~rasites Haemonchus and Trichostrongylus 
species. 
II. LITERATURE REVIEW 
A. PHENOTHIAZINE ANTHELMINTIC 
1. Chemical and Physical Characteristics: 
Phenothiazine is a three ring structure in which two 
benzene rings are linked by a sulfur and nitrogen atom as 
illustrated below: 
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Phenothiazine is known chemically as thiodiphenylarnine, 
or 2,3,5,6-dibenzo-l,4-thiazine, or dibenzoparathiazine. 
Its molecular weight is 199.26 (Vikhlaev, 1958; Windholz, 
1976). Substitutions at positions 2 and 10 abolish anthel-
mintic activity and significantly increase the action of the 
drug on the central nervous system (Esterada, 1956; Jones, 
1972; Byck, 1975; Rivera-Calimlim, 1977; Heath, 1978). Thus 
the phenothiazine tranquilizers which are substituted chem-
ical derivatives of phenothiazine are devoid of anthelmintic 
action. 
Pure phenothiazine is a tasteless pale lemon-colored 
powder with very low solubility in water, petroleum ether, 
and chloroform. The drug is variably soluble in benzene, 
hot acetic acid, mineral oil and alcohol. Dry phenothiazine 
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is relatively stable, but under moist conditions or upon 
exposure to sunlight spontaneous oxidative degradation 
occurs to 7-(10'-phenothiazinyl)-3H-phenothiazine-3-one 
(Swinyard, 1975; Windholz, 1976; Roseboom and Perrin, 1977; 
Roberson, 1977). 
2. Usage: 
In 1938 phenothiazine was first used in veterinary 
medicine as an anthelmintic, urinary antiseptic and 
insecticide (Vikhlaev, 1958; Swinyard, 1975). Currently, 
phenothiazine is used mainly as an anthelmintic, either 
alone or in combination with other agents. Phenothiazine 
is highly efficacous against Haemonchus, Oesophagostomum, 
Ostertagia, and Trichostrongylus infection of ruminants 
(Roberson, 1977); and mature Strongylus (Gibson, 1950), 
Triodontophorus and Trichonema (Brander and Pugh, 1971) 
species in horses. Synergistic effects are observed in 
sheep infested with nematodes when phenothiazine is used 
in conjunction with some organophosphorus compounds 
(Kingsbury, 1961; Sloan et al., 1961), or certain other 
drugs such as phenzidole (Hungerford, 1975). 
There are no rational indications for phenothiazine 
usage in dogs and cats, since both species are highly 
susceptible to phenothiazine poisoning (Buck et al., 1976a; 
Roberson, 1977). The drug is rarely used in pigs because 
of a similar susceptibility and limited efficacy (Thorning 
et al., 1942; Hungerford, 1975). 
The particle size of the drug markedly influences 
its pharmacologic action (Arundel, 1962). The microform 
is mostly effective against the smaller parasites, while 
the larger ones are more effective against the larger 
species (Brander and Pugh, 1971). 
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Oral drenching is the preferred method of phenothiazine 
administration especially in animals heavily burdened with 
parasites (Roberson, 1977) . 
3. Disposition and Fate: 
The principle biotransformation reactions of pheno-
thiazine occur in the liver of animals, and include oxida-
tive reactions (sulfoxidation, N-oxidation, and C-oxidation) 
followed by sulfate and glucuronic acid conjugations (Clare, 
1947; Roberson, 1977; Mitchell and Waring, 1979; Mitchell, 
1980). Some of the orally administer.ed phenothiazine is 
converted, likely by the epithelial enzymes of the gastro-
intestinal tract, to the sulfoxide form (Clare, 1947; 
Roberson, 1977). Phenothiazine sulfoxide is absorbed to-
gether with the parent compound and biotransformed by the 
liver microsomal enzyme system mainly to leucophenothiazone 
and leucothionol which are excreted in the urine (Clare, 
1947; Roberson, 1977). The highest tissue concentrations 
of phenothiazine and its metabolites are found in the liver 
and kidney (Ellison and Todd, 1957; Dobryina, 1963; 
Sundukov, 1963; Gyton et al., 1976). 
The urinary excretion of phenothiazine and its 
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metabolites seems to vary slightly from species to species. 
Unchanged phenothiazine, phenothiazone, and phenothiazine 
sulfoxide are urinary excretory products in sheep (Alexander 
et. al., 1958); and phenothiazine and/or phenothiazone occur 
i~ the urine of calves (Ellison and Todd, 1957). The uri-
nary metabolites in guinea pigs are leucophenothiazone 
sulfate, phenothiazine N-glucuronide, small amounts of free 
phenothiazine, phenothiazine sulfoxide, and phenothiazone 
(Mitchell and Waring, 1979). In rabbits, only phenothiazone 
and some chemically unknown red solid particles are detec-
table metabolites (Alexander et al., 1958). Generally, the 
parent compound, and seven metabolites (Leucophenothiazone, 
potassium leucophenothiazine sulfate, phenothiazone, leuco-
thionol, leucothionol glucuronide, thionol and phenothiazine 
sulfoxide) are identified as excretory products in various 
animal species (Foster et al., 1960). 
Upon exposure to air, the urinary metabolic products 
(leucophenothiazone and leucothionol) undergo further oxi-
dation to phenothiazone and thionol which impact a pink-red 
color to the urine (Clare, 1947). Similar discoloration 
may also occur in the milk (Brander and Pugh, 1971; 
Burrows, 1980). 
The phenothiazine tranquilizers undergo more extensive 
biotransforrnation than phenothiazine (Goldenberg et al., 
1964; Fishman and Goldenberg, 1965; Weir and Sanford, 1969; 
Weir and Sanford, 1972; Maylin, 1978). 
MAJOR METABOLITES OF PBENOTHIAZINE ANTHF.u'1INTIC IN ANIMALS 
Phenothiazine SUlf oxide 
Leuoophenothiazone Sulfate 
HO~H 
~ 
Leuoothionol 
Phenothiazone 
Leuoophen~thiazone 
0)0 
I 
Glu 
Phenothiazine N-Gluouronide 
Thionol 
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4. Toxicity and Clinical Effects: 
Toxicity of phenothiazine varies with both species 
and individuals. Horses are most susceptible, but dogs 
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and swine are also susceptible (Foster et al., 1960; Clarke 
and Clarke, 1967). Ruminants and birds are the least sus-
ceptible (Nicholson and McCulloch, 1942; Clarke and Clarke, 
1967). Sheep and goats are the most resistent species of 
the ruminants (Clarke and Clarke, 1967; Buck et al., 1976a). 
Severe stress factors enhance the toxicity of pheno-
thiazine in animals; thus debilitation of any kind, 
immaturity, malnutrition, and dehydration are important 
clinical potentiators of iatrogenic disease (Thorning et 
al., 1942; Koch, 1963; Clarke and Clarke, 1967; Salisbury 
et al., 1969). In the case of oral administration the size 
of the drug particle is also important in the toxicity. 
The smaller the particle size, the greater the frequency of 
poisoning (Radeleff, 1970). It is quite possible that the 
smaller particles are more readily absorbed from the 
gastrointestinal tract (Niazi, 1979). 
Photosensitization with keratitis may occur in cattle, 
swine, sheep, goats, and birds following phenothiazine 
administration (Thorning et al., 1942; Whitten and Filmer, 
1947; Buck et al., 1976a). Hemolytic anemia (mainly in 
horses and dogs) , and nervous disturbances (such as ataxia) 
are the most common manifestation of toxicity. Other ad-
verse effects include abortion in ewes during late gestation 
(Warwick et al., 1946), and decreased egg production in 
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birds (Nicholson et al., 1942). 
Upon exposure to sunlight, phenothiazine-photosensi-
tized animals manifest, within 12-48 hours of drug adminis-
tration , an acute dermatitis accompanied by keratitis 
(Thorning et al., 1942; Whitten and Filmer, 1947; Clarke 
and Clarke, 1967). The high level of circulating phenothia-
zine sulfoxide diffuses into the aqueous humor, and causes 
a photosensitized keratitis manifested by ulcerations of the 
cornea (Clare et al., 1947; Whitten and Filmer, 1947; Buck 
et al., 1976a). Sheep and goats are more resistant to 
photosensitization and keratitis than other species, because 
phenothiazine sulfoxide is rapidly biotransformed to the 
nontoxic metabolites, leucophenothiazone and leucothionol 
(Buck et al., l976a; Roberson, 1977). 
Hemolytic anemia, associated with phenothiazine tox-
icity, is observed mainly in horses and dogs (Clarke and 
Clarke, 1967; Buck et al., 1976a). This iatrogenic disease 
may be due to a metabolite or the presence of an impurity 
(diphenylamine) produced during drug preparation (Clarke 
and Clarke, 1967). In contrast to the phenothiazine 
anthelmintic, the phenothiazine tranquilizers apparently 
do not produce hemolysis of erythrocytes in vivo (Sinha 
and Sleight, 1968) or in vitro (Guth and Sprites, 1964). 
Phenothiazine has complex effects on the nervous system. 
Signs of neurotoxicity in the horse are weakness and ataxia. 
Dyspnea, colic, constipation, and diarrhea are also seen 
(Clarke and Clarke, 1967; Buck et al., 1976a). In pigs 
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incoordination, ataxia, paralysis and recumbency are ob-
served (Thorning et al., 1942; Burrows, 1980), while in 
sheep and cattle stiff gait, opisthotonus and incoordination 
are seen (Clarke and Clarke, 1967; Salisbury, 1969). 
Both phenothiazine and phenothiazine tranquilizers 
affect the endocrine system. Studies have shown that 
phenothiazine (Jha and Iyer, 1967), and especially pheno-
thiazine tranquilizers (De Weid, 1967; Gordon, 1967; Byck, 
1975, Merlis and Carone, 1975) act on the hypopituitary 
axis. The phenothiazine tranquilizers inhibit (De Weid, 
1967; Wakabayashi et al., 1980) as well as stimulate (De 
Weid, 1967) the secretion of growth hormone. 
Increased weight gain and appetite are associated with 
the use of phenothiazine tranquilizers in man (Pfister, 
1978; Mathues et al., 1959; Gordon, 1967; Byck, 1975). 
Similarly, the use of phenothiazine anthelmintic in lambs 
is reported to be associated with increased body weight 
(Varshney and Singh, 1976). Allen and Oldfield (1959) also 
reported significant weight gain and improved carcass qual-
ity in parasitized lambs treated with phenothiazine. The 
administration of a massive dose of phenothiazine (162.68 
gm/lb) to a calf reportedly caused only transient signs of 
toxicity without adversely affecting body weight gain and 
growth of the animal (Rogers et al., 1957). In one experi-
ment, however, moderately parasitized calves treated over 
121 days with various phenothiazine formulations were 
reported to have gained approximately 14% less weight than 
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the parasitized untreated calves (Cauthen, 1957). In an-
other experiment Cauthen (1952) fed small amounts of pheno-
thiazine daily to parasitized cows with calves for 3 
consecutive years, and observed no significant differences 
in weight gain between treated and untreated groups. In 
hens, higher doses of phenothiazine (1 gm daily for 85 days) 
were associated with decreased weight gain, but lower dos-
ages had no adverse effects (Nicholson and McCulloch, 1942). 
Toxic doses of phenothiazine were reported to decrease 
serum albumin levels in cattle, especially in animals on 
low protein ration (Ross et al., 1959). 
5. Necropsy Findings: 
Most necropsy lesions seen in phenothiazine poisoning 
are not pathognomic. Subcutaneous edema, keratitis in 
photosensitized animals (Thorning et al., 1942; Whitten and 
Filmer, 1947; Salisbury, 1969; Buck et al., 1976a), hemo-
lysis or jaundice (Clarke and Clarke, 1967; Radeleff, 
1970), kidney and liver hypertrophy, and noninflammatory 
necrotic changes with dark red colored urine (Salisbury, 
1969; Radeleff, 1970), are highly suggestive of phenothia-
zine poisoning. Significant histopathological changes in 
the thyroid (hypothyroidism), and degenerative changes in 
the anterior pituitary, adrenal corte~, and pancreas are 
associated with phenothiazine poisoning in sheep and cattle 
(Jha and Iyer, 1967). 
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B. DICHLORVOS AND CROTOXYPHOS 
1. Chemical and Physical Characteristics: 
a. Dichlorvos: The organophosphorus compound, 
dichlorvos (DDVP, Vapona®) is a derivative of phosphoric 
acid, and is chemically known as 2,2-dichlorovinyl dimethyl 
phosphate, or O,O,dimethyl-2,2-dichlorovinyl phosphate 
(WHO/FAO, 1967). It has the following structure: 
Pure dichlorvos is a clear liquid with a mild pleasant 
aromatic odor (WHO/FAO, 1967), and the molecular weight is 
220.98 (Windholz, 1976). It is less soluble in water and 
glycerine (approximately 1%) than in kerosene and mineral 
oil (approximately 3%) (WHO/FAO, 1967). It evaporates 
readily, and the vapor has an insecticidal activity (Van 
Raatle, 1970; Melnikov, 1971). 
b. Crotoxyphos: The organophosphorus compound, 
crotoxyphos (Ciodrin®, SD-4294) is a derivative of phos-
phoric and crotonic acids (Midwest Res. Inst., 1975). 
Chemically the compound is dimethyl 2-(a-methylbenzyloxy-
carbonyl)-1-methyl-vinyl phosphate, l-methyl-benzyloxy-
l-propen-2-yl dimethyl phosphate, or a-rnethylbenzyl-3-
(dimethyoxyphosphinyl-oxy)-cis-crotonate, and has the 
following structure: 
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Pure crotoxyphos is a light straw-colored liquid, 
with a molecular weight of 314.28 (Beynon et al., 1973; 
Windholz, 1976). It is soluble in water approximately 0.1% 
(Melnikov, 1971; Windholz, 1976), and variably soluble in 
kerosene, saturated hydrocarbons, acetone, chloroform, 
ethanol, and highly chlorinated hydrocarbons (Windholz, 
1976). 
2. Usage: 
a. Dichlorvos: The drug is widely used in veter-
inary medicine as a systemic and nonsystemic pesticide. 
Various dosage forms of dichlorvos, with or without other 
drug combinations, are used effectively to treat internal 
parasites in several animal species (Table 1) • 
Dichlorvos impregnated collars are used to control 
external parasites in dogs (Kibble, 1968; Walker and 
Stevenson, 1968), cats (Seawright and Costigan, 1975), 
goats (Darrow, 1973), and cattle (Harvey and Brethour, 
1970; Beadles et al., 1978). It is also applied topically 
to control external parasitic infestation in farm animals. 
Its combination with crotoxyphos (Ciovap®) has been used 
to control flies on sheared lambs (Campbell and Doane, 
1977) • 
SPECIES 
Pig 
Dog 
Cat 
Horse 
Man 
TABLE 1 
ANTHELMINTIC USAGES OF DICHLORVOS IN VARIOUS ANIMAL SPECIES 
PARASITIC INFECTION 
Oesophagostomum spp., Hyostrongylus rubidus, 
Ascaris ~' Trichuris suis. 
Ancylostoma caninum, A. tubaeforme, A. 
braziliense, A. duodenale, Uncinaria-steno-
cephala, Toxocara canis, T. cati, Toxascaris 
leonina, Trichuris vulpis~ ~~ 
Ancylostoma spp., Toxocara cati, !· canis. 
Gastrophilus intestinalis, G. nasalis, 
Strongylus vul~aris, s. e~Inum, Parascaris 
equorum, Oxyuris equi; PrC>stmayria vivipara. 
Ascaris lumbricoides, Trichuris trichiura, 
Schistosomia mansoni. 
REFERENCE 
Batte et al., 1965; 
Jacobs-,-1968 
Batte et al., 1966; 
Grey, I974 
Grey, 1974 
Drudge et al., 1975; 
Roberson; 1977 
Chavarria et al., 
1969; Katz-,-1977 
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Dichlorvos is used in public health to control house 
flies and plant insects (Gillet et al., 1972; Vettorazzi, 
1976; Derache, 1977). 
b. Crotoxyphos: Crotoxyphos (either alone or in 
combination with other organophosphorous compounds) has 
been used widely as an external pesticide to control 
livestock insects (Drummond et al., 1967; Beynon et al., 
1973; Kaemmerer and Buntenkotter, 1973; Midwest Res. Inst., 
1975; Campbell and Doane, 1977). Direct application of 
crotoxyphos to inanimate places burdened with insects or 
their larvae, is also a means of insect control (Beynon 
et al., 1973; Kaemmerer and Buntenkotter, 1973). 
3. Biotransformation: 
a. Dichlorvos: is rapidly biotransformed princip-
ally in the liver into pharmacologically inert metabolites 
(Casida et al., 1962; Hodgson and Caeida, 1962; Gaines et 
al., 1966; Derache, 1977). The following liver enzymes 
are involved in the metabolism of dichlorvos (Hodgson and 
Casida, 1962; Derache, 1977): an esterase that catalyzes 
hydrolysis of the drug at the P-0 vinyl group to produce 
the principle metabolite dimethyl phosphate, which is 
excreted in the urine, and dichloroacetaldehyde; a gluta-
thione dependent enzyme (S-alkyl transf erase) that attacks 
the methyl groups to produce desmethyl dichlorvos and s-
methyl glutathione; and microsomal mono-oxygenase systems 
that catalyze oxidative demethylation at the methyl groups 
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to produce desmethyl dichlorvos and formaldehyde. Des-
methyl dichlorvos is further hydrolyzed to monomethyl 
phosphate and then to inorganic phosphate and dichloro-
acetaldehyde. The latter compound is finally reduced to 
dichloroethanol, and trace amounts of dichloroacetic acid. 
Dichlorvos also undergoes extrahepatic biotransfor-
mation (Hodgson and Casida, 1962; Loeffler et al., 1971; 
Gillete et al., 1972; Derache, 1977). Four hours after 
infusion of dichlorvos into an isolated intestinal loop 
of the pig, dichlorvos, dimethyl dichlorvos, dichloroacet-
aldehyde, dichloroethanol, and dichloroacetic acid are 
detected in the lumen, whereas only dichloroethanol is 
found in the blood (Page et al., 1971). Within the body, 
the vinyl carbon atom is used for the synthesis of glycine, 
serine, and to a lesser extent glucose, cholesterol, fatty 
acids, and RNA (Hutson et al., 1971; Page et al., 1971). 
Some vinyl carbons are also expired as carbon dioxi de 
(Hutson et al., 1971; Page et al., 1971). Dichlorvos is 
rapidly biodegraded in vitro by the blood of rats, rabbits 
and humans (Blair et al., 1975). 
b. Crotoxyphos: is rapidly metabolized mainly 
into dimethyl phosphate and 1-phenylethyl acetoacetate 
(Chamberlain, 1964a, b). Following the oral admini stration 
of P32-labe.led crotoxyphos (66% a-isomer and 20 % S-isomer) 
to a lactating ewe, high concentrations of dimethyl phos-
phoric acid appear in the blood (within 6 hours) and urine 
(Chamberlain. 1964a). Less than 0.5% of crotoxyphos is 
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unchanged. Forty-eight hours postadministration, the urine 
contains about 79% of the administered dose mainly as 
dimethyl phosphoric acid. Quantitatively, crotonic acid 
and its derivatives are of lesser importance. The feces 
contain about 7.3% of the administered dose, and very small 
quantities of the radioactive substances are recovered in 
milk. 
Dermal applications of (99.2%) P32-labeled crotoxyphos 
(106 mg a-isomer) to a lactating goat (Chamberlain, 1964b) 
results in maximum blood level of radioactive substances 
four hours posttreatment. Only 11% of the administered 
dose is eliminated in the urine, and 0.12% appears in the 
feces. Negligible amounts of the drug appear in the milk. 
The major urinary metabolite of crotoxyphos is dimethyl 
phosphoric acid. Small quantities of crotonic acid and 
other metabolite2 are minor urinary products. The urine of 
the goat, however, contains fewer metabolites than that of 
the ewe (Chamberlain, 1964b). The metabolites appear to 
be nontoxic (Beynon et al., 1973). 
From in vitro studies (Beynon et al., 1973), it seems 
that crotoxyphos is extensively metabolized by the blood 
of cattle and pigs. 
4. Toxicity and Clinical Effects: 
a. General Mechanism and Signs of Organophosphorus 
Poisoning: The early signs of organophosphorus poisoning 
are caused by overstimulation of the parasympathetic 
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nervous system (Natoff, 1971; Solly, 1971; Gopal et al., 
1976; Buck, 1978). The organophosphorus compound inhibits 
the cholinesterase, and allow endogenous acetylcholine to 
accumulate. Generally, the signs may be divided into 
muscarinic, nicotinic and CNS effects (Natoff, 1971; Buck, 
1978) • The onset of signs of poisoning may vary from 
minutes to hours depending on the route of exposure and 
the dose of the drug. Muscarinic signs generally appear 
first followed by the nicotinic signs, and central signs 
may appear in severe toxic cases (Natoff, 1971; Solly, 
1971; Gopal et al., 1976). 
The general signs of poisoning in horses (Jackson et 
al., 1960; Radeleff, 1970), cattle (Tracy et al., 1960; 
Radeleff, 1970; Solly, 1971), sheep (Radeleff, 1970; Solly, 
1971; Gopal et al., 1976), dogs (Hazelwood et al., 1979) , 
cats (Bell et al., 1975), and pigs (Stanton et al., 1979) 
are excessive salivation, miosis, dyspnea, diarrhea, urin-
ation, colic, muscular fasciculation, ataxia, general weak-
ness progressing toward paralysis or convulsive muscular 
activity. Emesis may also occur in carnivores and omnivores. 
Dermatitis may be seen in dogs (Walker and Stevenson, 1968; 
Parkinson and Ketterer, 1969) and cats (Bell et al., 1975) 
wearing dichlorvos impregnated flea collars. 
Respiratory failure is the main cause of death in 
animals poisoned with organophosphorus compounds (Radeleff, 
1970; Natoff, 1971; Solly, 1971; Snow and Watson, 1973; 
Gopal et al., 1976). 
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b. Dichlorvos: When used rationally, dichlorvos is 
less toxic than most of the other organophosphorus compounds 
because it is rapidly metabolized and excreted from the body 
(Cochrane, 1963; Radeleff, 1970; Van Raatle, 1970). The 
estimated half-life of the drug in the blood of cattle is 
1.2 hour (Kaemmerer and Buntenkotter, 1973). The tissue 
residue of dichlorvos is so low that it is not a toxico-
logical problem (Casida et al., 1962; Hodgson and Casida, 
1962; Gillette et al., 1972; Kaemmerer and Buntenkotter, 
1973) • 
Dichlorvos apparently does not produce the delayed 
neurotoxicity (Durham et al., 1957; Stanton et al., 1979) 
which is associated with other organophosphorus compounds 
such as thiorthocresyl phosphate (Baron, 1981) • 
The acute Lo 50 values, and minimal toxic doses of 
dichlorovos for different animal species are presented 
in tables 2 and 3, respectively. The tolerated nontoxic 
doses of dichlorvos for different animal species are pre-
sented in table 4. 
It is apparent from tables 2, 3, and 4 that the 
technical form of dichlorvos is more toxic than the formu-
lated one, which releases the active ingredient more 
slowly. 
c. Crotoxyphos: Toxicological studies indicate also 
that crotoxyphos, when used rationally, is of low toxicity 
to animals (Weidenbach and Younger, 1962; Knapp et al., 
1967; Radeleff, 1970). The rapid metabolism and excretion 
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TABLE 2 
ACUTE LD50 VALUES OF DICHLORVOS FOR DIFFERENT ANIMAL SPECIES 
ROUTE OF 
SPECIES SEX ADMINISTRATION 
MOUSE 
MOUSE 
MOUSE 
RAT 
RAT 
CHICKS 
PIGEON 
DOG 
M 
F 
M 
F 
M 
F 
M 
F 
M 
M 
DOG (puppy) 
CAT 
PIG 
* **Subcutaneous 
Oral 
S/C* 
Oral 
Oral 
Oral 
Oral 
Oral 
Oral 
Dermal 
Dermal 
Oral 
Oral 
Oral 
Oral 
Oral 
Oral 
Oral 
LD50 
mg/kg 
124 
24 
FORMULATION 
36.5\ emulsion 
36.5\ emulsion 
145 V-2 
135 V-2 
139 
133 
80 Technical 
56 Technical 
107 Technical 
75 Technical 
97 Analytical 
Standard 
Quality 
14.8 Technical 
16.79 
100-316 
244.7 Formulated** 
83.8 Formulated** 
157 Unformulated 
Polyvinyl chloride resin formulation 
REFERENCE 
Yamashita, 1962 
Wagner and 
Johnson, 1970 
Haley et al. , 
1975- -
Durham et al. , 
1957; Gaines, 
1960 
Bradway et al. , 
1977 
Sherman and Ross, 
1961 
Hattorik, 1974 
Snow and Watson, 
1973 
Grey, 1974 
Grey, 1974 
Stanton et al. , 
1979 
TABLE 3 
MI NIMAL TOXIC DOSES OF DICHLORVOS FOR DIFFERENT ANIMAL SPECIES 
ROUTE OF 
SPECIES ADMINISTRATION 
SHEEP oral 
CATTLE (calf) Or.al 
CATTLE Oral 
HORSE Oral 
PIG Oral 
DOG (Beagles). Oral 
DOG (Greyhound) Oral 
I.V.*** 
I .V.*** 
*Redi stilled 
**Polyvinyl chloride resin formulation 
***Intravenous 
MINIMAL TOXIC 
DOSE mg/kg 
25 
10 
27 
25 
320 
148. 5 
11 
4.4 
2.2 
FORMULATION 
Technical* 
Technical 
Formulated** 
Formulated** 
Technical 
Technical 
Emulsified with 
0.9\ sodium 
chloride 
REFERENCE 
Radeleff and Woodard, 1957 
Radeleff and Woodard, 1957 
Tracy et al., 1960 
Jackson et al., 1960 
Stanton et al . , 1979 
Hazelwood et al., 1979 
Snow and Watson, 1973 
N 
...... 
TABLE 4 
TOLERATED NON-TOXIC DOSES OF DICHLORVOS FOR DIFFERENT ANIMAL SPECIES 
SPECIES 
SHEEP 
CATTLE 
CATTLE 
ROUTE OF 
ADMINISTRATION 
Oral 
Oral 
Dermal 
Dermal 
HORSE Inhalation 
PIG Oral 
PIG (pregnant) Oral 
PIG (pregnant) Oral 
DOG (Beagles) Oral 
RAT Oral 
*Redistilled 
TOLERATED DOSE 
10 mg/kg 
0.91 mg/kg, daily for 7 days 
1' dust (56.7 gm/animal) 
2\ solution (200 ml) 
3 0.5 mg/ft daily for 22 days 
180 mg/kg 
25 mg/kg, daily for last 30 
days of gestation 
66 gm 
41.58 mg/kg 
1000 mg/kg diet, for 90 days 
**Polyvinyl chloride resin formulation 
FORMULATION 
Technical* 
REFERENCE 
Radeleff and Woodard, 
1957 
Tracy et al., 1960 
Radeleff, 1970 
Technical* Tracy~ al., 1960 
Formulated** Stanton et al., 1979 
Formulated** Standen~ al., 1979 
Formulated** Jacobs, 1968 
Formulated** Ward and Glicksberg, 
1971 
Technical Durham et al., 1957 
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of the drug may account for its low toxicity tRadeleff, 
1970). Brahman cattle, however, are highly susceptible 
to crotoxyphos poisoning tRadeleff, 1970; Greer et al., 
1973) and concentrations as low as 0.144%-0.3% produced 
severe toxic reactions in that species (Radeleff, 1970). 
The acute Lo50 values and tolerated nontoxic doses of 
crotoxyphos for different animal species are presented in 
tables 5 and 6, respectively. 
In animals suffering from crotoxyphos poisoning mus-
cular weakness and diarrhea are the main signs observed 
(Weidenbach and Younger, 1962; Radeleff, 1970). Skin 
lesions may occur following dermal application of the drug 
in pigs (Palmer and Schlinke, 1971) . 
Since crotoxyphos does not cause demyelination of the 
peripheral nerves in chicken, it is possible that it does 
not produce delayed neurotoxicity in other species (Midwest 
Res. Inst., 1975). 
5. Significance of Blood Cholinesterase Activity: 
The exact significance of erythrocyte or plasma cho-
linesterase depression associated with exposure to organo-
phosphorus compounds is not fully understood (Derache, 
1977; Roberson, 1977). Animals exposed to organophosphates, 
especially in chrouic cases, have been known to tolerate 
low blood cholinesterase levels without untoward effects 
(Solly, 1971; Khan, 1973; Roberson, 1977). In some cases, 
the erythrocyte and plasma cholinesterase levels are normal, 
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TABLE 5 
ACUTE LD50 VALUES OF CROTOXYPHOS FOR DIFFERENT ANIMAL SPECIES 
ROOTE OF 
LD50 ADMINIS-
SPECIES SEX TRATION mg/kg FORMULATION REFERENCE 
MOUSE M Oral 39.8 Vorob'eva and 
Lapchenko, 1973 
MOUSE Oral 89 Technical 83% Midwest Res. 
Oral 288 Wettable powder Inst., 1975 
25% 
Oral 61 3.2 lb/gal 
(0.16 solution 
ml/kg) 
RAT M Oral 38.4 Vorob'eva and 
Lapchenko, 1973 
RAT Oral 125 Kaemmerer and 
Buntenkotter, 
1973; Wiswesser, 
1976 
RAT M Oral 110 Technical Midwest Res. 
F Oral 74 Technical Inst., 1975 
Oral 74- 125 Technical 
Oral 288 Wettable powder 
25% 
Oral 21.3 Emulsible concen-
(O. 213 trate 3. 2 lb/gal 
ml) 
F S/C 148.8 
M Dermal 375 
F Dermal 202 
CHICKS M Oral 111 Technical Midwest Res. 
F Oral 147 Technical Inst., 1975 
RABBIT Oral 384 Kaemmerer and 
Butenkotter, 
1973 
RABBIT Dermal 742 Technical Midwest Res. 
Dermal 384 Technical Inst., 1975 
Dermal >200 3.2 lb/gal 
M Dermal 338 Emulsible con-
centrate 
Dermal >l,250 Wettable powder 
25% 
CAT M Oral 802 Vorob'eva and 
Lapchenko, 1973 
SPECIES 
SHEEP 
GOAT 
CATTLE 
CATTLE 
HORSE 
PIG 
RAT 
TABLE 6 
TOLERATED NON-TOXIC DOSES OF CROTOXYPHOS FOR DIFFERENT ANIMAL SPECIES 
ROUTE OF 
ADMINISTRATION 
Dermal 
Dermal 
Dermal 
Dermal 
Dermal 
Dermal 
Oral 
TOLERATED DOSE 
0.5\ and l\ emulsion 
0.5\ and l\ emulsion 
2\ emulsion 
0.5\ emulsion, 1.5 gal/animal/ 
week for 16 weeks 
2\ emulsion, 1 pt. 5 times 
every 3 days. 
2% in oil, 4 oz. daily for 
7 days 
0.5% emulsion 
0.01 mg/kg 
REFERENCE 
Weidenbach and Younger, 1962 
Weidenbach and Younger, 1962 
Weidenbach and Younger, 1962 
Knapp et al., 1967 
Knapp et al., 1967 
Knapp et~., 1967 
Weidenbach and Younger, 1962 
Vorob'eva and Lapchenko, 1973 
N 
U1 
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while the enzyme activity of the nervous system is depre-
ssed (Solly, 1971). Erythrocyte and nervous system cholin-
esterases, however, have similar physiological properties 
(Solly, 1971). The measurement of erythrocyte cholines-
terase activity rather than plasma or CNS cholinesterase 
is the best guide for detecting an animal's exposure to 
organophosphorus compounds (Natoff, 1971; Gopal et al., 
1976; Derache, 1977; Purshottam and Kaveeshwar, 1979). 
This is especially true in ruminants because of the asso-
ciated low plasma cholinesterase activity. 
Following exposure to organophosphorus compounds, the 
recovery of the inhibited plasma cholinesterase activity 
occurs at a faster rate than that of the erythrocyte 
(Solly, 1971; Ward and Glicksberg, 1971; Snow and Watson, 
1973; Gopal et al., 1976). 
The normal cholinesterase values for different animal 
species are presented in table 7. 
a. Dichlorvos Induced Anticholinesterase Effects: 
Changes in the blood cholinesterase activity following expo-
sure of different animal species to dichlorvos are presented 
in table B. 
Following the dermal contact with dichlorvos impreg-
nated collars, some dogs (Walker and Stevenson, 1968) and 
cats (Bell et al., 1975) may exhibit depressed blood 
cholinesterase activity. 
Inhibition of the blood cholinesterase activity by 
dichlorvos appeared not to be potentiated by certain 
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llORKAL CBOLINEST!B.A.SE VALUES FOR Dl!'FUEllT ANIMAL SPl!:CU::S 
SPECIES 
SHEEP 
Sllr:EP 
SHEEP 
SHEEP 
SllUP 
SllEEP 
SHEEP 
CUTU 
CAl"ILE 
CUTU (dif-
ferent bruda) 
ESTl!B.A.S! 
erythrocyte CbE 
erythrocyte CbE 
pluma CbE 
vhole blood Cb! 
erycbrocyce CbE 
plaame CbE 
• rytbrocyce CbE 
plane ChE 
CSF ChE 
erythrocyte ChE 
e~hrocyte CbE 
plan& CbE 
whole blood CbE 
erythrocyte ChE 
erythrocyte CbE 
plume CbE 
erychroc:yce CbE 
whole blood CbE 
erytbroc:yte Cb! 
RESULT 
0,08-0.40 Apll/hr 
0.39 ApH/hr 
0.06 ApH/hr 
0.14-0,27 lpH/hr 
0. 76 ApB/JO at.in 
268-J82 mU/ml 
59.4 uM/4 at.in/ml 
7.3 uM/4 at.in/ml 
l.5 µH/4 min/ml 
105 uM/ml/30 min 
0.35 ApH/hr 
0.16 ApH/hr 
0.14 ApH/hr 
0.69 ApH/45 min 
0.65 ApH/hr 
0.03 ApH/hr 
0. 65 ApH/15 min 
42.l ~lCO,/ml/min 
l. 2 IJM 
CATl'L! erythrocyte Cb! l.62 ~H 
(Aberdeen Angus) 
CilTLI? pl•- ChE 
CATTLE 
(Calf) 
BORS! 
BORS! 
BORSE 
PIG 
PIG 
PIG 
DOG 
DOG 
DOG 
DOG (H) 
DOG (F) 
DOG 
CAT 
GlJINEA PIG 
llAllBIT 
llAllBIT 
RABBIT 
RABBIT 
RAT 
RAT 
l«JUSE 
MOUSE 
CHICON 
RllESUS 
l«JNICEY 
lWI (M) 
lWI (P) 
HAN 
erythrocyte ChE 
plan& ChE 
CSF ChE 
whole blood 
erychroc:yce CbE 
plasma CbE 
erychroc:yt• CbE 
pluu CbE 
erytbroc:yce ChE 
plaa ... CbE 
erythrocyte CbE 
pl&- ChE 
CSF ChE 
erythrocyte ChE 
plan& ChE 
erythrocyte ChE 
plaaia CbE 
erytbroc:yce CbE 
plume CbE 
erythroc:yce ChE 
plaaa ChE 
CSF ChE 
erychroc:yce ChE 
plaama ChE 
erychroc:yce ChE 
plane CbE 
erythrocyte ChE 
plume Ch£ 
erychroc:yte ChE 
pl&aa CbE 
plume CbE 
erythrocyte ChE 
pl&na CbE 
erytbroc:yce CbE 
plume CbE 
erytbroc:yte Cb! 
plaaa CbE 
CSF 'ch! 
erythroc:yte c~ 
plane CbE 
erychroc:yce ChE 
pl&ama ChE 
erytbroc:yce ChE 
plume CbE 
erythroc:yce CbE 
plume ChE 
erythrocyte CbE 
plan& Cb! 
erythrocyte CbE 
pl&ama ChE 
plume CbE 
erythrocyte ChE 
plum& ChE 
erytbroc:yce ChE 
pluma CbE 
erythrocyte Ch! 
plan& CbE 
e rythrocyce CbE 
plu .. CbE 
258 mU/ml 
199.6 uHol/4 min/ml 
10. l uMol/4 min/ml 
2.0 uMol/4 min/ml 
0.39 ApH/hr 
0.18 ApB/hr 
0.62 ApH/hr 
0, 78 ApB/45 min 
0.66 ApB/20 min 
O. 7l Apll/25 min 
0.46 Apll/hr 
U4,6 uHol/4 min/ml 
l3 .4 uMol/4 min/ml 
2.2 uMol/4 adn/1111. 
0.32 uH/min 
0.16 uH/min 
O.lJ ApH/hr 
0.16 Apll/hr 
0.63 ApH/45 min 
0.67 Apll/30 min 
48.3 llKol/4 min/ml 
~5.l uHol/4 min/ml 
2.4 uMol/4 min/ml 
10 • .5 uMol/3 min/ml 
10.3 uMol/3 min/ml 
10.6 uMol/3 min/ml 
12.l uMol/3 min/ml 
l.O uMol/lllin/ml 
0. 9 uMol/min/ml 
0.10 Apll/hr 
0 , 56 ApB/hr 
19.9 IJ.lCOs/ml/min 
0.32 Apll/hr 
0 .58 Apll/hr 
0.20 ApH/hr 
0.22 Apll/hr 
184 .8 uMol/4 min/ml 
30.3 llKol/4 min/ml 
7.2 uMol/4 ado/ ml 
2 .l 11H/ml/min 
0. 76 uH/ml/mia 
l. 0 11Hol/mia/ml 
0. 9 uMol/mia/ml 
0.19 lpB/hr 
0.21 ApH/hr 
l.4 uMol/min/ml 
5. 6 uMol/min/1111 
0.12 Apll/hr 
l.36 Apll/hr 
l.l uMol/mia/ml 
19.8 uMol/min/ ml 
24.l uM/min/ml 
6. 8 ~l/mia/ml 
l. 7 uMol/mia/ ml 
114 ulCOa / ml/m.in 
88 .5 lJlCOa / ml/ min 
107.7 IJ.l,C01 /ml/min 
88.3 ~lCOa/ml/min 
0. 75 ApH/t\r 
0. 70 Apll/hr 
!i!Tl!OD 
modified Michel• 
mod itied Michel 
modified Michel 
modified Michel 
biodyn&lllic/bmc 
automated procedure 
aemiautomated method 
of Lavine .!! !!_., 
Butrin color 
ruction 
modified Michel 
mod 1 tied Mich• l 
modified Michel 
modified Michel 
modified Michel 
manoucric 
Fleiaher and Pope 
(•lightly modified) 
Flei1her and Pope 
(1li1htly modified) 
b iod yn&lllic a/ bmc 
aucouced procedure 
aeaiaucomated method 
of Levine et al., 
1966 --
modified Michel 
modified Michel 
modified Michel 
modified Michel 
REFEllENCE 
Radelett and Woodward, 1956 
Krucka~berg and Veal:\leber, 1973 
Crook&henk and Pal.mer, 1978 
Silveatri, 1977 
Crook&h&nk and Pel111&r, 1978 
Mazelwood and Hea th, 1976 
Anderson .!! !!_., 1969 
Kruc:kaaberg and Veacweber , 1973 
Palmer et al,, 1963 
S1lveatrl,l977 
Kruckenberg and Vestweber, 1973 
Silveatri, 1977 
Willa, 1972 
Patty 4Dd Lovell, 1958 
Petty and Lovell, 01958 
Crookshank and Palmer, 1978 
Hazelwood and Keach , 1976 
Palmer et al., 1963 
Kruckaali&ri""and Vaacweber, 1973 
Silvestri, 1977 
Silveacri, 1977 
aeiai&ucomated method Hazelwood and Heath, 1976 
of Lavin• et al. , 
1966 --
c:olorimetric 
modified Michel 
modified Michel 
aadaucomated method 
of Levine et al., 
1966 --
autouced 
automated 
Cralllll&r and Peoplea, 
1971 
modified Michel 
llWlOMtric 
modified Michel 
modified Michel 
aeiai&ucoma c ed method 
ot Lavine ec al. , 
1966 --
pH - stat 
Cramaer and Peoples, 
1971 
mod itied Michel 
Craamer and Peoples, 
1971 
modified Mictiel 
Cranmer and Peoples, 
1971 
manomecric 
Cranmer and Peoples, 
1971 
Cl&DOIDetric 
manometric 
Michel 
Willa, 1972 
Kruckauberg 3nd Vestweber, 1973 
Silvucri, 1977 
Hazelwood and Heath, 1976 
Ward and Beaa, 1971 
Ward and Besa, 1971 
Craamer and Peoples, 1973 
Kruckaaberg and Veacweber, 1973 
Willi, 1972 
Kruckenberg and Veal:\leber, 1973 
Kruckanberg and Vesl:\leber, 1973 
lludwood and Keacti, !976 
Willa, 1972 
CramDer and Peoplas , 1973 
Kruckenberg and Vescweber, 1973 
Cranmer and Peoples . 1973 
Kruckenberg and Ves l:\leber, 1973 
Cranmer and Peoples, 1973 
Wills, 1972 
Cranmer and Peoples, 1973 
Willa, 1972 
Willi, 1972 
Michel, 1949 
•coaaulc ctie oriainal reference• tor procedural detail• of th• modification& of Michel's method, 
TABLE 8 
EFFECTS OF DICllLORVOS ON BLOOD CHOLINESTERASE ACTIVITIES IN DI FFERENT ANIMAL SPECIES. 
ROUTE OF 
AOMINI-
SPECIES STRATION 
SHEEP 
CATTLE 
(calf) 
CATTLE 
HORSE 
HORSE 
(foal) 
HORSE 
HORSE 
PIG 
PIG 
(preg-
nant.) 
DOG 
DOG 
DOG 
MOUSE 
RAT 
Oral 
Oral 
Oral 
Oral 
Oral 
Oral 
Oral 
Inhal-
a t.ion 
Oral 
oral 
Oral 
Oral 
Oral 
Oral 
Oral 
*Redist illed 
DOSE 
25 mg/kg 
10 mg/kg 
FORMULATION 
0 . 91 mg/kg daily Tec hnica l * 
for 7 days 
2.28 mg/kg daily Technical* 
for 12 days 
35.8 mg/kg 
10&20 mg/kg 
25&50 mg/kg 
0. 5 mg/ft 3 dai l y 
1-16 mg/kg daily 
for 30 days 
5&25 mg/kg daily 
for last 30 days 
of gescacion 
29.7-148.5 mg/kg 
11&2 2 mg/kg 
H.58 mg/kg 
500 mg/kg diet 
for 24 hours 
500 mg/kg diet 
for 90 days 
f'ormulated** 
Formulated*** 
Technical 
Technical* 
f'ormulated** 
f'onnulated** 
f'ormula ted** 
Technical 
Formulated** 
V-2 
Technical 
i. • decrease 
ESTERASE 
EChE 
EChE 
EChE 
EO\E 
PChE 
W.B. ChE 
PChE 
W.B. ChE 
W.B. ChE 
EChE 
EChE 
PChE 
EChE 
PChE 
EChE 
EChE 
PChE 
EChE 
PChE 
PChE 
EChE 
PChE 
~ • approximately 
> • more than 
EFFECT 
.j. >90 \ 
¥1-75\ 
.jl\,70\ 
.jl\,6Q\ 
"" 85\ 
-i.trans -
i tory 
.j. 48\ . 
.jl\.47\ 
j. 90\ 
.. 82\ 
~60\ 
.j.>90\ 
.j.>85 \ 
"" 37\ 
.j. 67' 
~SO\ 
¥1-60\ 
-1'1- 50 \ 
**Polyvinyl chloride resin 
pelleced formualt i on 
***Polyvi nyl chloride pasce 
formulation 
EO\E • erythrocyte cholinesterase 
PO\E • plasma cholinesterase 
W.B. ChE • whole blood cholinesterase 
REFERENCE 
Radeleff, 1957 
Radeleff , 1957 
Tracy !E. al. , 
1960 
Be llo ~ !!_., 
1974 
Bello !E. a l. , 
1974 
Jackson et 
al. , l9Go 
Tracy et al., 
1960 - -
St ancon et 
a l., 1979 
Stanton et 
al., 1979 
Hazelwood et 
al., 1979 
Snow and 
Watson , 19"/3 
Ward and 
Glicksberg, 
1971 
Wagner and 
Johnson, 
1970 
Dur ham e t 
al., 1957 
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organophosphorus compounds including crotoxyphos (Knapp et 
al., 1967; Collins et al., 1971; Vestweber and Kruckenberg, 
1972; Carter and Maddux, 1974; Cohen and Ehrich, 1976). 
b. Crotoxyphos Induced Anticholinesterase Effects: 
The effects of crotoxyphos on the blood cholinesterase 
activity in several animal species are presented in table 9. 
Two hundred and fifty parts per million of crotoxyphos 
in the diet of rats had no inhibitory effect on the brain 
cholinesterase activity (Midwest Res. Inst., 1975). Seven 
hundred and fifty parts per million, however, depress the 
enzyme in the brain of rats (Midwest Res. Inst., 1975). 
Chronic administration of crotoxyphos (0.01 mg/kg) to rats 
for 10 months, did not inhibit the cholinesterase activity 
(Midwest Res. Inst., 1975). 
6. Other Physiological Effects: 
a. Dichlorvos: Elevated hematocrit and total plasma 
protein values may occur in adult dogs treated with dichlor-
vos (Snow and Watson, 1973). In puppies and cats, however, 
there are no changes in the hematocrit, serum cholesterol, 
and total plasma protein values following dichlorvos 
administration (Grey, 1974). 
Daily administration of dichlorvos (1-16 mg/kg) to 
young pigs (30 days) has no effect on weight gain or feed 
consumption (Stanton et al., 1979). Similar results are 
observed in suckling piglets after treatment of their dams 
(Collins et al., 1971). Following the administration of a 
TABLE 9 
EFFECTS OF CROTOXYPHOS ON BLOOD CHOLINESTERASE ACTIVITY IN DIFFERENT ANIMAL SPECIES 
ROUTE OF 
SPECIES ADMINISTRATION DOSE ESTERASE EFFECT REFERENCE 
SHEEP Dermal o.5i emulsion W.B. ChE + 42\ Weidenbach and Younger, 1962 
GOAT Dermal 0.5\ emulsion W.B. ChE + 61\ Weidenbach and Younger, 1962 
Dermal 1.0\ emulsion W.B. ChE ~100\ 
CATTLE Dermal o.5i emulsion W.B. ChE + 69\ Weidenbach and Younger, 1962 
(calf) Dermal 2.0\ emulsion W.B. ChE +100\ 
CATTLE Dermal 0.15-0.6\ emulsion W.B. ChE No Change Matthysse and Lisk, 1968 
(calf) 
CATTLE Dermal 0.5\ emulsion, W.B. ChE + 85\ Weidenbach and Younger, 1962 
weekly for 16 wks 
Dermal 2.0\ + 76\ 
HORSE Dermal 2.0% in oil, 4 oz/ PChE + 89\ Knapp et al. , 1967 
day for 7 days 
Dermal 2.0\ emulsion PChE ¥\.76\ 
1 pt/3 days for 
5 times 
PIG Dermal 1.0\ emulsion W.B. ChE ¥\.50\ Palmer and Schlinke, 1971 
(1 liter) 
DOG Oral 2.02 mg/kg/day EChE ¥\.50\ Vorob'eva and Lapchenko, 
for 30 days 1976 
W.B. ChE = whole blood cholinesterase 
PChE = plasma cholinesterase 
EChE = erythrocyte cholinesterase w 
0 
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single or repeated reconunended dosages of dichlorvos to 
cattle (Ribelin and Macklin, 1971), sows (Collins et al., 
1971; Witherup et al., 1971; Grey, 1974; Stanton et al., 
1979), rat (Tracy et al., 1960; Pambska et al., 1978), 
rabbit (Pambska et al., 1978), or bitches (Grey, 1974) 
during various stages of pregnancy, no adverse drug effects 
are seen during gestation, at parturition, or during the 
postnatal development of the progenies. Clinical and 
experimental data have demonstrated that dichlorvos induces 
parturition and reduces the farrowing period when admin-
istered during the last trimester of pregnancy (Batte et 
al., 1969; Shell, 1975; Young et al., 1979). Currently it 
is recommended as an ecbolic drug to reduce stillbirths 
in farrowing sows (Shell, 1975). Dichlorvos is generally 
reported to be nonteratogenic in rabbits (Vogin and Carson, 
1971; Schwetz et al., 1979), mice (Schwetz et al., 1979), 
chicken (WHO/FAO, 1970), or rats (WHO/FAQ, 1970). Terato-
genic effects, however, have been observed in chicken 
embryos (WHO/FAO, 1970). Recent reports indicate that other 
organophosphorus compounds have overt or subtle embryotoxic 
and fetotoxic effects in animals (Derache, 1977; Knox et al., 
1978). 
b. Crotoxyphos: The daily administration of this 
compound to dogs (2.02 mg/kg for 30 days), results in a 
decreased serum albumin level and increased globulin level 
(Vorob'eva and Lapchenko, 1973). Following topical 
application of crotoxyphos (1.0%) to pigs, no significant 
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difference in weight gain is seen between the drug-treated 
and nontreated animals (?almer and SchlinKe, 1971). 
Similarly, feeding different levels of the drug (5, 15 and 
45 ppm) to dogs for 12 weeks do not affect the growth rate 
or organ weight (Midwest Res. Inst., 1975). Crotoxyphos is 
nonteratogenic in the chicken embryo (Midwest Res. Inst., 
1975). The drug does not adversely affect gestation in the 
cow (Ribelin and Macklin, 1971). 
C. COMBINED EFFECTS OF PHENOTHIAZINE 
ANTHELMINTIC AND ORGANOPHOSPHORUS 
INSECTICIDES. 
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Under field conditions more than one drug may be used 
concu=rently to treat livestock diseases because of the 
convenience and economy of this practice. Drug potentia-
tion or adverse reactions may arise as a result of drug 
interaction (Gaines, 1962; Gopal, 1976; Khan, 1973). The 
phenothiazine anthelmintic is often used concurrently with 
other anthelmintics or ectoparasiticides (Kingsbury, 1961; 
Sloan et al., 1961; Hungerford, 1975). 
Numerous reports indicate that phenothiazine tran-
quilizers potentiate organophosphorus poisoning in several 
animal species, such as man (Arterberry et al., 1962), 
rat (Gaines, 1962; Michalek and Stavinoha, 1978), and sheep 
(Gopal et al., 1976). 
The potentiated inhibition of brain cholinesterase 
following phenothiazine tranquilizer (chlorpromazine) 
administration is less when dichlorvos rather than physo-
stigmine is used concurrently (Michalek and Stavinoha, 
1978). 
Gopal et al. (1976) have shown, however, that the 
phenothiazine tranquilizer triflupromazine not only in-
creases the signs of coumaphos toxicosis in sheep, but 
also potentiates the coumaphos-induced inhibition of eryth-
rocyte and plasma cholinesterase activities. 
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The use of phenothiazine tranquilizers as an adjunc-
tive agent in the treatment of organophosphorus poisoning 
is therefore very controversial (Arterberry, 1962; Wills, 
1970; Michalek and Stavinoha, 1978). Phenothiazine tran-
quilizers, however, are used in the treatment of organo-
phosphorus poisoning in man (Wills, 1970), although fatal 
drug interactions may occur (Arterberry, 1962). The 
observation that the anticholinesterase agent physostigmine 
is efficacious in antagonizing the CNS effects of pheno-
thiazine tranquilizer poisoning in man (Wang and Marlowe, 
1977; Weisdorf et al., 1978), emphasizes the fact that the 
mechanism by which the drug potentiates the adverse CNS 
effects of the organophosphorus compounds is not fully 
known. 
The concurrent use of the phenothiazine anthelmintic 
and certain organophosphorus pesticides, produced syner-
gistic anthelmintic action in sheep (Kingsbury, 1961; 
Sloan et ~l., 1961). In contrast, phenothiazine anthel-
mintic does not potentiate the toxicity of several organo-
phosphorus pesticides (including crotoxyphos and dichlor-
vos) when therapeutic doses of both types of compounds 
are used in healthy calves (Schlinke and Palmer, 1973). 
Similarly, significant potentiation is not observed when 
phenothiazine anthelmintic and coroxon or coumaphos are 
used in sheep (Malone, 1962). Phenothiazine in combination 
with coumaphos, however, depresses blood cholinesterase 
activity more than does coumaphos alone (Malone, 1962). 
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The above effect is not observed with coroxon-phenothia-
zine combination (Malone, 1962). The organophosphorus 
compounds differ quantitatively with reference to their 
pharmacological and toxicological properties and these 
differences may determine the nature of drug potentiation 
seen when used concurrently with phenothiazine. It is 
interesting to note also, that phenothiazine anthelmintic 
when used alone does not depress the blood cholinesterase 
activity of sheep at dose levels between 0.4-2 gm/kg body 
weight (Malone, 1962). 
The role stressors play in iatrogenic diseases can not 
be overlooked when drug interactions are being evaluated. 
Factors such as species, age, sex, health and nutritional 
state of the animal may modify or enhance organophosphorus 
poisoning (Gaines, 1962; Durham, 1967; Radeleff, 1970; 
Natoff, 1971; Khan, 1973; Gopal et al., 1976). With regards 
to livestock animals, Go.pal et al. (1976) showed that sheep 
maintained on low dietary protein were more susceptible 
to the organophosphorus (coumaphos) toxicity than those on 
normal protein diet. These investigators also observed 
that lambs fed a low dietary protein ration were more sus-
ceptible than lambs fed a normal ration to the potentiation 
effect of coumaphos and triflupromazine. In contrast, the 
effects of other stressors on the drug interaction of 
organophosphates and phenothiazine in sheep are not fully 
known. 
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D. MODIFICATIONS OF MICHEL'S ELECTROMETRIC METHOD 
TO MEASURE BLOOD CHOLINESTERASE ACTIVITY 
IN ANIMALS. 
Numerous procedures have been developed to determine 
blood cholinesterase activities of man and animals (Wit t er, 
1963; Aldrich, 1969; Augustinsson, 1971; MacQueen and 
Plaut, 1973; Silk et al., 1979). Modifications of the 
method originally described by Michel (1949) are most com-
monly used. The method used here in this thesis is a 
modification of Michel's electrometric method. 
Michel's electrometric method for measurement of the 
erythrocyte or plasma cholinesterase activity is princip-
ally based on the hydrolysis of the choline ester sub-
strate (acetylcholine) by the cholinesterase enzyme of 
the biologic sample used (Michel, 1949): 
ChE 
(CH3 ) 3 N-CH2-cH20-CO-CH 3 + H2o --+ (CH 3 ) 3 N-CH2-cH 20H 
(Acetylcholine) (Choline) 
+ CH3COOH 
(Acetic Acid) 
This enzymatic reaction results in acetic acid pro-
auction. The acetic acid dissociates liberating hydrogen 
ions which decrease the pH of the reaction mixture. 
0 
II 
CH3COOH --~ [H+] + [ o-c- c ] 
Electrornetric determination of the change in the p H 
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produced over a definite period of time le.9. l hr} at a 
specific temperature le.9. 2s0 c) represents the enzyme 
activity (e.g., 6pH/hr). The pH is measured with a glass 
electrode using a pH meter. 
Heparin is used as the only anticoagulant in order to 
avoid enzyme inactivation due to removal of magnesium and 
calcium ions present in the blood (Witter, 1963; 
Augustinsson, 1971). 
The temperature of the reaction medium plays a crit-
ical role in the rate of the reaction and is thus important 
in determining the cholinesterase activity. A 1° C change 
in temperature of the reaction medium results in a 5.5% 
and 3.0% change in plasma and erythrocyte cholinesterase 
activity respectively (Ellin and Vicario, 1975). 
One may consider the fact that during a reaction the 
6pH is measured after a fixed time interval rather than 
the amount of acid production at different times, a minor 
drawback of Michel's electrometric method. In addition, 
the instability of the pH of the phosphate buffer creates 
an inconvenience (Witter, 1963; Augustinsson, 1971). 
Personal observations indicate a significant decrease in 
the pH shelf-life of the buffer reagent after 7-10 days. 
Michel's technique, however is as sensitive and repro-
ducible as other standard methods (such as pH-stat, Hestrin 
color reaction, and Acholest methods) in measuring small 
variation in the blood cholinesterase activity (Witter, 
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1963; Pearson and Walker, 1968; Aldrich, 1969; Augustinsson, 
1971; MacQueen and Plaut, 1973). The simplicity of Michel's 
method, therefore, makes it a very valuable assay technique 
for research in the determination of cholinesterase activity 
(Aldrich, 1969; MacQueen and Plaut, 1973), and for the 
routine diagnosis of organophosphorus poisoning (~ldrich, 
1969; Holmstedt, 1971). 
Since domestic animals (especially ruminants) are 
characterized by having relatively low blood cholinesterase 
activity, various modifications of the original Michel's 
method are used to enhance the products of the enzymic 
reaction and thus the ~pH (table 10) • To obtain satisfac-
tory results with the electrometric method as originally 
described by Michel (1949), the volume of the blood sample 
used is increased (Frawley and Fuyat, 1957; Callahan and 
Kruckenberg, 1967; Kruckenberg and Vestweber, 1973), the 
incubation time is lengthened (Callahan and Kruckenberg, 
1967), or the reaction temperature is increased (Silvestri, 
1977). The recent modifications described by Silvestri 
(1977) to measure erythrocyte and plasma cholinesterase 
activity in domestic animals involve using shorter times o f 
incubation (15-60 minutes depending on the animal species) 
coupled with an increase in the reaction temperature to 
37° c. No significant difference between washed and non-
washed erythrocyte cholinesterase activity occurs using 
these modifications (Silvestri, 1977}. 
The procedural modification of Ellin et al. (1973) 
TABLE 10 
MODIFICATIONS OF THE ELECTROMETRIC METHOD OF MICHEL USED TO MEASURE 
BLOOD CHOLINESTERASE ACTIVITIES IN DIFFERENT ANIMAL SPECIES 
SPECIES 
Dog 
Horse, Goat 
Pig 
Goat, Horse, Pig, 
Dog, Cat, Rabbit, 
Guinea pig 
Guinea pig, Goat, 
cattle, Rabbit, 
Cat, Horse, Rat, 
Sheep, Dog, Mouse 
Sheep, Goat, 
cattle, Pig, 
Horse, Dog 
ESTERASE 
EChE 
W.B.ChE 
EChE 
EChE 
W.B.ChE, 
EChE and 
PChE 
EChE and 
PChE 
MAIN MODIFICATIONS* 
Higher concentration of washed 
erythrocytes 
Substituting whole blood for 
the washed erythrocytes 
Doubling the volume of erythro-
cytes and acetylcholine 
Increasing erythrocytes volume 
eightfold, and various incu-
bation times are used 
Doubling the volume of erythro-
cytes, and tripling the volume 
of plasma 
Incubation temperature is 
increased to 37 C. and time of 
incubation is reduced 
ADVANTAGES 
Useful in animals with low 
cholinesterase activity 
Faster than Michel's method 
Useful in animals with low 
cholinesterase activity 
Useful in animals with low 
cholinesterase activity 
Useful in animals with low 
cholinesterase activi ty 
Sensitive, high.0.pH reading 
short incubation time, both 
macro and semimicro method 
could be used, and nonwashed 
erythrocyte may be used 
REFERENCE 
Frawley and 
Fuyat, 1957 
Palmer et 
al., 1963 
Moncol and 
Batte, 1964 
Callahan and 
Kruckenberg, 
1967 
Kruckenberg 
and 
Vestweber, 
1973 
Silvestri, 
1977 
*Consult the original references for procedural details of the modifications of Michel's electrometric 
method. 
EChE = Erythrocyte cholinesterase; PChE = Plasma cholinesterase; W.B.ChE = Whole blood choli nesterase 
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involves shortening the incubation time from 60 to 17 
minutes, and increasing the sample volume five-fold. This 
modification may prove to be of diagnostic usefulness in 
veterinary medicine. 
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III. MATERIALS AND METHODS 
1. Animals: 
Forty, approximately 3-month-old lambs of mixed breeds 
(mean body weight 26.38±0.45 lb) were used in this study. 
The animals were from an area endemic for nematodes. The 
lambs were individually weighed and randomly numbered 1-40. 
They were divided into two major groups, A (1-20), and B 
(21-40). The animals in both groups were vaccinated with 
ovine ecthyrna vaccine, and Clostridium perfringens antitoxin 
type C and D. Following 20 days of acclimatization, each 
major group was randomly subdivided into four groups CA1 , A2 , 
A3 , A4 and B1 , B2 , B3 , B4 ) of five lambs each, and housed in 
individual pens. Each group received concentrate given 
twice a day while hay and water were available ad libitum. 
All the groups of lambs, upon parasitological exam-
ination of their fecal samples were found to be clinically 
infected with Haemonchus and Trichostrongylus species. 
Each lamb in groups B1 -B4 was drenched on the first day of 
acclimatization with 0.5 ounce levamisole hydrochloride per 
50 lb. body weight. On the 16th day of acclimatization, 
the lambs in groups B1 -B4 were also treated orally with 
thiabendazole, 1 gm per lamb. All the lambs in groups 
B1-B4 were certified free of the above mentioned nematodes. 
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2. Experimental Procedures: 
Experiment I: Prior to initiation of the drug treat-
ments, each lamb was sheared, exposing the entire spinal 
portion of the animal. 
During the experiment, the lambs in each group were 
treated during a 29 day period with phenothiazine anthel-
. t' a d · ®b (2 3 · hl min ic an Ciovap • % Die orvos and 10.0% Crotoxy-
phos) as outlined in Table 11. This was followed by a 30 
day posttreatment period. 
Each lamb in groups A1 , A2 , B1 , and B2 was sprayed 
with approximately 1550 ml of 0.25% Ciovap® emulsion. 
® Spraying with Ciovap was repeated every two weeks for a 
total of three treatments. Concurrently with the initial 
Ciovap® application a phenothiazine anthelmintic bolus 
(12.5 gm) was administered orally with a balling gun to 
each lamb in groups A1 , A3 , B1 , and B3 . Four days later, 
each phenothiazine treated lamb was given one half of a 
bolus (6.25 gm). This treatment was repeated every three 
days for a total of nine treatments. 
The lambs were kept under constant observation during 
the 29 day treatment period, and examined each day for the 
remaining 30 days (posttreatment period). 
Experiment II: After experiment I was concluded a 21 
day study was carried out to determine the effect of a 
aSioux City Serum Co., Sioux City, Iowa. 
bShell Chemical Co., Agricultural Division, Animal Health, 
San Ramon, California. 
TABLE 11 
TREATMENT SCHEDULE AND CALENDER OF EXPERlMENTAL EVENTS 
OF LAMBS SPRAYED WITH CIOVAP® AND/OR GIVEN 
PHENOTHIAZINE ANTHELMINTIC 
GROUP TREATMENT 
Clinical Parasitism No Clinical Parasitism 
C&P 
c 
p 
Control 
CALENDER OF EXPERIMENTAL EVENTS 
-1 0 !.(C,P) 2 
-
3 4 5(P) 6 
8(P) 9 10 ll(P) 12 13 14(P) 15(C) 
17(P) 18 19 20(P) 21 22 23(P) 24 
26(P) 27 28 ~(C,P) 30 31 32 33 
35 36 37 38 39 40 41 42 
44 45 46 47 48 49 50 51 
53 54 55 56 57 58 59 60(P) 
62(C,P) 63 64 65 66 67 68 69 
71 72 73 74 75 76 77 78 
80 
-1 to 0 Pretreatment Period - - - - - - - - - - - - - (2 days) 
1 to 29 Treatment Period (Experiment I) - - - - - - (29 days) 
30 to 59 Posttreatment Period (Experiment I) - - - - (30 days) 
60 to 62 Treatment Period ~periment II) - - - - - - (3 days) 
63 to 80 Posttreatment Period (Experiment II) - - - -(18 days) 
Blood samples collection days are underlined. 
P - Phenothiazine anthelmintic treatment 
C - Ciovai)B> Spray 
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7 
16 
25 
34 
43 
52 
6l(P) 
70 
79 
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second 3 day drug exposure period on the animals used in 
experiment I. Each lamb in groups A1 , A3 , B1 , and B3 
received one gram of phenothiazine powderc (54% phenothia-
zine as the active ingredient) mixed in the feed for three 
consecutive days. On the third day of phenothiazine admin-
istration, each lamb in groups A1 , A2 , B1 , and B2 was 
sprayed with one gallon of 0.25% Ciovap® emulsion. All the 
groups were kept under observation for 18 days before 
termination of the experiment. 
3. Parasitological Examination: 
Fecal samples were collected from all the groups prior 
to the initiation of experiment I, at the end of the 29-day 
treatment regimen (experiment I), and at the end of the 
experiment II. A fecal concentration-centrifugation tech-
nique was used to identify the helminthic's eggs so as to 
determine the nature of clinical parasitism . 
4. Clinical Examination: 
The time of onset of clinical signs, the nature of 
signs observed, and the time of death were recorded through-
out both experiments. Dead animals were necropsied. 
5. Collection and Assays of Blood Samples: 
Baseline values of erythrocyte (EChE) and plasma 
c ® Phenothiazine Premix , West Agro-Chemical Inc. 
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cholinesterase lPChE) activity, and total plasma protein 
(TPP) were determined on two consecutive days just prior 
to initiation of the treatments. During experiment I, 
determinations of cholinesterase (ChE) activities were 
conducted on blood samples collected from all groups six 
hours following the first treatment with phenothiazine and 
® Ciovap , and thereafter at 24 hour intervals for 31 days 
with the exception of days: 5, 8, 12, 18, 19, 25 and 26. 
After the 31st day, blood samples were collected twice a 
week for 5 weeks and then 15 days later on the termination 
day of the experiment II. 
Heparinized vacutainer tubesd were used to collect 
approximately 5 ml of blood by jugular venipuncture. The 
samples were immediately kept in crushed ice until they 
were centrifuged. The blood samples were centrifuged for 
15 minutes at 3,000 rpm at 4°c, and the plasma and erythro-
cytes were separated. The plasma was transferred to clean 
dry rubber-stoppered test tubes. The erythrocyte samples 
were washed once with approximately the same volume of cold 
0.9% sodium chloride solution by mixing and then centrifu-
gation for another 15 minutes at 3000 rpm at 4°c. The 
supernatant fluid was discarded to obtain the erythrocytes. 
The washed erythrocyte and plasma samples were stored at 
-4o0 c until the EChE and PChE activities were determined by 
a modification of Michel's electrometric method (Silvestri, 
d ® B-D Vacutainer , Becton-Dickenson, Rutherford, New Jersey. 
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1977) • 
One aliquot of 0.2 ml of plasma or erythrocytes sample 
was added to 3 ml of distilled water in a 10 ml beaker and 
mixed. Erythrocyte solutions were hemolyzed by incubation 
for 10 minutes at room temperature. Three ml of the buffer 
(pH 8.10) were added, mixed and incubated in a 37°c water 
bath for 10 minutes. At the end of 10 minutes the pH value 
of the sample was measured with a glass electrode using a 
Corning pH metere, to the nearest 0.01 pH unit (pH1 ). One 
aliquot of 0.12 ml of a 7.5% acetylcholine iodide aqueous 
solution was added to the mixture, mixed and incubated in 
the water bath at 37°c for 30 minutes. The pH (pH 2 ) of the 
reaction mixture was measured at the end of 30 minutes. 
The change in the pH representing the enzymatic activity 
(~pH/30 minutes at 37°c) was calculated: 
~pH = pH1 - pH2 - pH(control) 
The assay was conducted in duplicates. A ~ontrol to which 
no acetylcholine iodide solution was added was also included. 
Total plasma protein values (gm/100 ml) were determined 
with a clinical refractometer£. 
6. Statistical Analysis of Data: 
An analysis of variance and least square analysis were 
used for all the groups. 
ecorning Digital 109, general purpose pH meter. 
£National Instrument, Baltimore, Maryland. 
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IV. RESULTS 
Experiment I 
Clinical Signs of Toxicity: When compared to the con-
trol groups A4 and B4 there was no observable adverse 
effects of phenothiazine anthelmintic treatment alone on 
the behavior of the lambs in groups A3 and B3 over the per_ 
iod of the trial (table 12). In contrast, following each 
Ciovap® spray application (table 12) signs of toxicity were 
observed within 40 minutes in 20% to 60% of lambs that 
received only Ciovap® (groups A2 and B2), and within 30 
minutes in 20% to 80% of lambs that received concurrent 
phenothiazine treatment (groups A1 and B1). The affected 
lambs were from both parasitized A1 and A2 , and nonpara-
sitized B1 and B2 groups. 
In the affected groups CA1 , A2 , B1 , and B2) the 
severity of the signs of toxicity varied from one lamb to 
another, but qualitatively the signs were characteristic 
of cholinesterase inhibition. There were no observable 
differences in the qualitative signs of Ciovap® toxicity 
between affected groups A1 , A2 , B1 , and B2 • Affected 
lambs were restless and manifested respiratory distress 
(dyspnea) with mucous nasal discharge. Muscular fasci-
culation and tremors were seen along the abdominal muscles 
and hind limbs. Frequent urination and/or defecation 
accompanied with straining were seen during Ciovap® 
TABLE 12 
MEAN TIME OF ONSET OF CLINICAL SIGNS OF ~OXICITY 
AND THE NUMBER OF LAMBS AFFECTED AFTER CIOVAP® 
AND/OR PHENOTHIAZINE ANTHELMINTIC TREATMENT. 
Mean Time 
Number of Onset 
of Ciovap® of Signs 
GrouE Treatment AEElication (minutes) 
Clinical 
Parasitism 
Al Ciovap® & 1 30± 9. O* Phenothiazine 2 15±10. 0 
3 25± 3. 0 
A2 Ciovap® 1 10±5. 0 
2 40 
3 10±3. 0 
A3 Phenothiazine 0 0 
No Clinical 
Parasitism 
Bl Ciovap® & 1 12±3. 0 
Phenothiazine 2 11 
3 1.5±5. 0 
B2 Ciovap® 1 30±10.0 
2 30 
3 26 
B3 Phenothizaine 0 0 
*±SEM 
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Number 
of Lambs 
Affected 
3 
2 
3 
2 
1 
3 
0 
4 
1 
3 
2 
1 
1 
0 
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toxicity. As the signs of toxicity progressed, some of the 
affected lambs suffered from muscular weakness which was 
manifested as difficulty in supporting body weight on the 
hind limbs (figure 1), and ataxic gait. Consequently, some 
of the affected lambs became depressed (figure 2), hypokin-
etic, weak, and recumbent. Twenty-four hours following 
Ciovap® spray, some lambs still manifested mild signs of 
straining during defecation or urination, diarrhea or ano-
rexia. Generally these toxic signs gradually disappeared 
within 2-3 days except in one lamb (group B1) which became 
progressively depressed, emaciated and recumbent after the 
third Ciovap® spray. The lamb developed respiratory compli-
cations (dyspnea and extensive nasal discharges) and died on 
the fifth day following the third Ciovap® application. 
Mortality and Necropsy Findings: Two lambs died, one 
from group A3 on day 4, and another lamb from group B3 on 
day 8 of the trial from causes unrelated to the study. 
Pleuropneumonia and extensive thoracic adhesions were seen 
following necropsy examinations of the lambs. One lamb 
died from group B1 5 days following the third Ciovap® 
spray. Necropsy examination of the group B1 lamb indicated 
congestion of the tracheal and laryngeal mucosal lining with 
petechial hemorrhages (figure 3). The lungs and liver were 
congested. There were lesions of pleuropneumonia with 
extensive thoracic adhesions. Extensive petechial hemor-
rhages were seen on the myocardium and myocardial membranes 
Figure 1: Lordosis in a lamb from group A2 manifesting 
difficulty in supporting body weight on the 
hind limbs (one hour after the first Ciovap® 
spray in experiment I). 
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Figure 2a-2b: Signs of depression in some group A1 
(figure 2a) and B1 lf igure 2b) lambs after 
® Ciovap spray. 
2-a 
2-b 
Figure 3: Congestion and petechial hemorrhages in the 
mucosa! lining of the larynx and trachea of 
a lamb (group s1 ) which died 5 days after 
® the third Ciovap spray (experiment I). 
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(figure 4). Hemorrhagic areas in the mucosa! lining of the 
small and large intestine, and congested areas on the rumen 
serosal membrane were also seen. 
Erythrocyte Cholinesterase (EChE) Activity: The long-
term treatment effects on the EChE activity of the parasi-
tized and nonparasitized lambs are shown in figures 5 and 6 
respectively. The EChE activities measured weekly of 
groups A1 and A2 lambs were significantly decreased from 
those of the phenothiazine treated group (A3 ) and the un-
treated control group (A4 ) following each of three applica-
tions of Ciovap® (figure 5). Similarly, the EChE activities 
of lambs in groups B1 and B2 were significantly decreased 
from those of groups B3 and B4 (figure 6). The extent of 
EChE inhibition between parasitized (A1 and A2 ) and non-
parasitized (B1 and B2 ) groups was not significantly 
different. 
Concurrent phenothiazine anthelmintic administration 
to groups A1 and B1 did not significantly change the extent 
of EChE inhibition from the Ciovap® treated groups A2 and 
B2 • Phenothiazine treatment alone (groups A3 and B3 ) did 
not siginif icantly change EChE activities from their 
respective control values (A4 and B4 ). 
The short term effect of each of three Ciovap® appli-
cations on EChE activities of (A1 , A2 , B1 , and B2 ) lambs 
is shown in figure 7. The inhibition of EChE activities 
was most significantly different from the phenothiazine 
Figure 4: Severe petechial hemorrhages on the myo-
cardium and myocardial membranes of the lamb 
(group B1 ) which died 5 days after the third 
® Ciovap spray (experiment I). 

Figure 5: Changes in EChE activities (~xperiment I) 
of clinically parasitized lambs treated with 
® Ciovap spray and/or phenothiazine anthelmin-
tic. Each point represents the mean ±SEM of 
5 lambs (except A3 , n=4). The values of week 
0 represent average pretreatment levels of 2 
successive days prior to treatment. (a) is 
significantly (.P<0.05) different from control 
(A4 ) value. (b) is significantly (P<0.05) 
different from phenothiazine treated (A3 ) 
value. 
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Figure 6: Changes in EChE activities (experiment I) of 
clinically nonparasitized lambs treated with 
Ciovap®spray and/or phenothiazine anthelmin-
tic. Each point represents the mean ±SEM of 
5 lambs (except s 3 and B1 5 days after the 
3rd Ciovap® spray, n=4). The values of week 
O represent average pretreatment levels of 2 
successive days prior to treatment. (a) is 
significantly (P<0.05) different from control 
(B4) value. (b) is significantly (P<0.05) 
different from phenothiazine treated (B3) 
value. 
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Figure 7: The short term treatment effects during 
experiment I of the three C•lst, 02nd, A3rd) 
biweekly applications of Ciovap® spray on 
mean EChE activities in clinically parasi-
tized and nonparasitized groups of lambs. 
Each point represents the mean ±SEM of 5 
lambs (except A3 and B3 , n=4). The mean 
EChE activities of the control groups (DA4 , 
0B4) and the phenothiazine treated C•A3 , eB3) 
during the entire time interval are shown at 
the extreme left of the graph. (a) is signi-
ficantly (P<0.05) different from control 
value. (b) is significantly (P<O. 05) differ·· 
ent from the phenothiazine treated value. 
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® 
treated or control groups 24 hours following the Ciovap 
applications. The severity of EChE inhibition increased 
with each Ciovap® spray. ® In each of the Ciovap treated 
groups rapid recovery of the inhibited EChE activity 
® 
occurred within 48 hours following a Ciovap spray. In 
each case the 6-hour posttreatment level was reestablished. 
The pretreatment levels of EChE activities, which ranged 
® from 0.65 to 0.72 6pH/30 min., of the Ciovap treated 
lambs were never attained during the posttreatment period 
(figure 8). They remained consistently lower than pre-
treatment levels. 
Plasma Cholinesterase (PChE) Activity: The treatment 
effects on PChE activities of the parasitized and nonpara-
sitized lambs are shown in figures 9 and 10. It was noticed 
that during the trial, the control as well as the treatment 
values progressively decreased to levels below the pretreat-
ment values. 
Relative to PChE activities of the control A4 and the 
phenothiazine treated A3 groups, each of the three Ciovap® 
sprays resulted (within one week of application) in a 
significant inhibition of PChE activities of group A1 lambs, 
while PChE activities of group A2 lambs were only signif i-
. ® . 
cantly inhibited after the first and third Ciovap appli-
cation (figure 9). The PChE activities of concurrently 
phenothiazine treated lambs (A1 ) were significantly lower 
® 
than those of the Ciovap treated A2 lambs after the second 
Figure 8: The EChE activities during posttreatment 
period of experiment I after the third 
Ciovap® application of clinically parasi-
tized and nonparasitized lambs. Each point 
represents the mean ±SEM of 5 lambs (except 
a1 , n=4 after day 5). The mean ±SEM of 
pretreatment levels of each group are shown 
at the extreme left of the graph. 
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Figure 9: Changes in PChE activities (experiment I) 
of clinically parasitized lambs treated 
with Ciovap® spray and/or phenothiazine 
anthelrnintic. Each point represents the 
mean ±SEM of 5 lambs (except A3 , n=4). 
The values of week 0 represent average 
pretreatment levels of 2 successive days 
prior to treatment. (a) is significantly 
(P<0.05) different from control CA4 ) 
value. (b) is significantly (P<0.05) 
different from phenothiazine treated (A3 ) 
value. (c) is significantly (P<0.05) 
different from Ciovap® treated (A2 ) value. 
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Figure 10: Changes in PChE activities (experiment I) 
of clinically nonparasitized lambs treated 
with Ciovap® spray and/or phenothiazine 
anthelmintic. Each point represents the 
mean ±SEM of 5 lambs (except s 3 and s 1 
5 days after the 3rd Ciovap® spray; n=4). 
The values of week 0 represent the average 
pretreatment levels of 2 successive days 
prior to treatment. (a) is significantly 
(P<0.05) different from control CB4) value. 
(b)is significantly (P<0.05) different from 
phenothiazine treated (B3) value. 
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Ciovap® spray (figure 9). In the nonparasitized lambs, 
PChE activities of B1 lambs were significantly inhibited 
relative to the phenothiazine treated B3 and control B4 
groups after the first and third Ciovap® applications 
(figure 10). Throughout the trial there was no significant 
difference between the PChE values of B2 , a3 , ftnd B4 groups 
(figure 10). The PChE activities of the B1 lambs that 
received concurrent phenothiazine treatment were consistent-
ly lower than those of the Ciovap® treated B2 lambs (figure 
10) • 
The extent of PChE inhibition between parasitized and 
nonparasitized groups was not significantly different (fig-
ures 9 and 10) • 
Total Plasma Protein (TPP) Concentration: The treat-
ment effects on TPP levels of parasitized and nonparasi-
tized lambs are shown in figure 11. Generally, during 
the trial, parasitized control lambs (A4 ) manifested higher 
TPP values than nonparasitized control (B4 ) lambs. Groups 
A2 and B2 lambs that received only the Ciovap® treatment 
manifested a transient but significant decrease in TPP 
values from the control A4 and B4 values respectively. 
The TPP values of A2 lambs were only significantly lower 
than those of the control A4 values on days 15, 20, 27 and 
28 of the treatment period. Similarly, TPP values of B2 
lambs were significantly lower than those of control B4 
values only on days 3, 4, and 30 of the treatment period. 
Figure 11: Changes in TPP values (experiment I) of 
lambs treated with Ciovap® (C) and/or 
phenothiazine anthelmintic (P). Each 
point represents the mean of 5 lambs 
(except A3 and B3 , n=4). The values of 
day 0 represents average pretreatment 
levels of 2 successive days prior to 
treatments. (a) is significantly 
(P<0.05) different from control value. 
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The TPP values of B2 lambs were consistently lower than 
those of A2 lambs during the trial. 
During the trial, group A1 and B1 lambs that received 
® both Ciovap spray and phenothiazine manifested different 
TPP levels in comparison to control A4 and B4 values 
respectively. Relative to control A4 TPP values, the A1 
lambs manifested significantly lower TPP concentration on 
the days shown in figure 11. In contrast, B1 lambs mani-
fested significantly higher TPP values than the control B4 
lambs. 
The TPP values of A1 lambs tended to be lower than 
those of A2 lambs during the trial. The decrease was sig-
nificant toward the end of the treatment period. In con-
trast, TPP values of B2 lambs were significantly lower than 
the values of B1 lambs throughout most of the trial period. 
Phenothiazine treatment of group A3 lambs resulted in 
significantly lower TPP values than those of control A4 
lambs. In contrast, TPP concentrations of B3 lambs were 
significantly higher than those of the control B4 lambs. 
No significant difference was seen between TPP values of 
A3 and B3 lambs (figure 11). 
Weight Gain: When the lambs were weighed 65 days 
after the initial weighing at the beginning o f the t r ial, 
all the groups gained weight (table 13). The phenothiazine 
treated groups A3 and B3 , however, gained signif icantly 
more body weight than the other groups. There were no 
TABLE 13 
MEAN ±SEM WEIGHT GAIN OF THE LAMBS 
IN 65 DAYS DURING EXPERIMENT I 
Group* 
Clinical 
Parasitism 
No Clinical 
Parasitism 
* 
Treatment 
Ciovap & Phenothiazine 
Ciovap 
Phenothiazine 
None 
Ciovap & Phenothiazine 
Ciovap 
Phenothiazine 
None 
n = 5, except A3 , B1 and B3 ; n = 4 
** 
Mean Weight 
Gain (lb) 
3.7±1.5 
5.4±1.9 
a** 14.4 ±5.0 
7.1±2.7 
5.6 ±1.4 
5. 5± 1.1 
15.0±3.9a 
4.6±0.8 
Mean values not showing the same superscript letter 
are significantly different (P<0.05). 
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significant differences in the weight gain among the other 
groups (table 13). 
Experiment II 
Clinical Signs of Toxicity: Relative to untreated 
control A4 and B4 lambs, phenothiazine anthelmintic treat-
ment alone (groups A3 and B3 ) had no observable adverse 
effects on the animal behavior over the period of the trial 
(table 14). 
Similarly, in experiment II, the challenge dose of 
Ciovap® spray application (1 gallon of 0.25% emulsion) pro-
duced signs of toxicity in the sprayed lambs (A1 , A2 , B1 , 
and B2 ) (table 14). The signs of toxicity were observed 
within 16 minutes in 40% to 60% of lambs that received 
. ® ( Ciovap alone A2 and B2 ) and within 18 minutes in 50% to 
69% of lambs that received concurrent phenothiazine treat-
ment (A1 and B1 ). The severity of the observed signs of 
toxicity varied from one lamb to another but they were 
qualitatively characteristic of ChE inhibition. There was 
no observable difference in the signs of Ciovap toxicity 
between the affected groups. Affected lambs were restless, 
manifested dyspnea with mucous nasal discharge. Frequent 
urination and/or defecation accompanied with straining were 
also seen. Some of the lambs became depressed at a later 
. ® 
stage of Ciovap toxicity. One to two days following 
Ciovap® spray, some lambs still manifested mild signs of 
diarrhea, anorexia or depression. These toxic signs 
TABLE 14 
MEAN TIME OF ONSET OF CLINICAL SIGNS OF TOXICITY 
AND THE NUMBER OF LAMBS AFFECTED AFTER 
CIOVAP AND/OR PHENOTHIAZINE 
ANTHELMINTIC TREATMENT 
Mean Time No. of 
of Onset of Lambs 
78 
Group Treatment Signs (Minutes) Affected 
Al Ciovap & 18 ±7.0* 3 
Phenothiazine 
A2 Ciovap 16 ±5.0 2 
A3 Phenothiazine 0 0 
Bl Ciovap & 17 ±2.0 2 
Phenothiazine 
B2 Ciovap 13 ±4.0 3 
B3 Phenothiazine 0 0 
*±SEM 
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gradually disappeared within 2 to 3 days. No mortality 
occurred during the trial. 
Erythrocyte Cholinesterase Activity: The treatment 
effects of phenothiazine and Ciovap® on the EChE activities 
of the lambs previously used in experiment I are shown in 
figure 12. A challenge dose of Ciovap® spray application 
significantly decreased the EChE activities of group A2 
lambs relative to values for the phenothiazine treated A3 
and control A4 groups; while the EChE activities of group 
A1 lambs which received concurrent phenothiazine treatment 
was inhibited to a lesser extent. Compared to the control 
A4 values, the EChE activities of A1 lambs were signifi-
cantly inhibited on day 3 following Ciovap® spray. Similar-
ly, the EChE activities of group B1 and B2 lambs were sig-
nificantly decreased from those of the phenothiazine treated 
B3 or control B4 groups (figure 12). Concurrent phenothia-
zine treatment (A1 and B1 ) did not significantly change the 
extent of EChE inhibition from the Ciovap® treated A2 and 
B2 lambs. 
Phenothiazine administration alone to groups A3 and 
B3 for 3 consecutive days did not significantly change 
EChE activities from the control values A4 and B4 (figure 
12) . 
Plasma Cholinesterase Activities: The treatment 
effects of phenothiazine and Ciovap® on the PChE activities 
Figure 12: Changes in EChE activities (experiment II) 
of lambs treated with Ciovap® and/or 
phenothiazine anthelmintic. Each point 
represents the mean ±SEM of 5 lambs (except 
A3 , B3 , and B1 ; n=4). Preexperimental EChE 
values are shown at the extreme left of the 
graph. (a) is significantly (P<0.05) dif-
ferent from control value. (b) is signi-
ficantly (P<0.05) different from pheno-
thiazine treated value. 
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of the lambs are shown in figure 13. Group A2 manifested 
significantly lower PChE activities from the phenothiazine 
treated A3 and the control A4 groups on day 3 following 
Cicvap® spray. No significant changes occurred in PChE 
activities of group A1 lambs. One day after Ciovap® appli-
cation, PChE activities of group B1 lambs were signifi-
cantly decreased from the values of the phenothiazine 
treated B3 or control B4 groups. Values of B2 lambs were 
not significantly different from B3 and B4 groups (figure 
13). Three days following Ciovap® spray, PChE activities 
of both B1 and B2 lambs became significantly decreased 
from control values tB4 ). 
Prior administration of phenothiazine to groups A1 and 
B1 lambs for 3 consecutive days did not significantly af-
fect the extent of PChE inhibition relative to the values 
. ® 
of the Ciovap treated A2 and B2 lambs (figure 13) . 
Phenothiazine administration alone for 3 consecutive 
days (A3 and B3 ) did not significantly change PChE acti-
vities from the values of control (A4 and B4 ) lambs as 
seen 24 hours after the last phenothiazine dose (figure 
13). On the third day after the last phenothiazine dose, 
PChE activities of only groups (B3 ) lambs were significantly 
lower than the control (B4 ) values (figure 13). 
Total Plasma Protein (TPP) Concentration: The treat-
ment effect on TPP levels of both the major groups (A & B) 
lambs are shown in figure 14. Similar to experiment I, 
Figure 13: Changes in PChE activities (experiment I I ) 
of lambs treated with Ciovap® and/or 
phenothiazine anthelmintic. Each point 
represents the mean ±SEM of 5 lambs (except 
A3 , B3 , B1 ; n=4). Preexperimental PChE 
values are shown at the extreme left of 
the graph. (a) is significantly (P<0.05) 
different from control value. (b) is 
significantly (P<0.05) different from 
phenothiazine treated value. 
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Figure 14: Changes in TPP levels (~xperiment II) of 
the lambs treated with Ciovap® and/or 
phenothiazine anthelmintic. Each point 
represents the mean of 5 lambs (except 
A3 , a1 , B3 ; n=4). Preexperimental TPP 
values are shown at the extreme left of 
the graph. (a) is significantly differ-
ent from the respective control value 
(P<0.05). 
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control A4 lambs manifested higher TPP levels than those of 
b h . 1 . ® 1 B4 control lam s. T e sing e Ciovap spray a one to groups 
A2 and B2 did not significantly change TPP concentration 
from control A4 and B4 lambs respectively (figure 14) . 
During the experiment TPP values of B2 lambs were consis-
tently lower than those of A2 lambs (figure 14). 
In this experiment, group A1 and B1 lambs that received 
both Ciovap® spray and phenothiazine manifested different 
TPP levels relative to those of control A4 and B4 lambs 
respectively (figure 14). In comparison to control A4 TPP 
values, A1 lambs showed lower TPP concentrations which 
became significantly low on day 3 after Ciovap® spray (fig-
ure 14). In contrast, throughout the experiment, B1 lambs 
manifested higher TPP values than those of control B4 lambs. 
The TPP values of A1 lambs were consistently but not signi-
ficantly lower than those of A2 lambs, whereas TPP values of 
B1 lambs were significantly higher than those of B2 lambs 
(figure 14). 
Group A3 lambs that received phenothiazine alone mani-
fested significantly lower TPP values than those of control 
A4 lambs (figure 14). In contrast, TPP of B3 lambs that 
received phenothiazine alone were significantly higher than 
control B4 values on day 1 after the last phenothiazine 
dosage (figure 14). These values of TPP became lower on 
day 3 with no significant difference from control B4 lambs. 
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V. DISCUSSION AND CONCLUSION 
Experirnent I 
Clinical Signs of Toxicity: ® Ciovap spray applications 
of 1550 ml/lamb/2 weeks for 3 applications (table 11) pro-
duced signs of toxicity characteristic of ChE inhibition. 
® Some of the Ciovap sprayed lambs, however, did not manifest 
any observable signs of toxicity (table 12). Individual 
differences within an animal species in response to organo-
phosphorus toxicity are not unexpected (Khan, 1973) • There 
were no differences in the signs of Ciovap® toxicity 
between parasitized (A1 and A2) and nonparasitized (B1 and 
B2) lambs. This could be due to the fact that the 
clinically parasitized lambs were in good physical condi-
tion throughout the trial, and no adverse effects were 
seen due to parasitism. The weight gain of the parasi-
tized lambs were also comparable to those of nonparasitized 
ones (table 13). 
Combinations of phenothiazine anthelmintic and organo-
phosphorus compounds were reported to act synergistically 
as endoparasiticides in sheep (Kingsbury, 1961). Phenothia-
zine tranquilizers, however, are well known potentiators 
of organophosphorus compounds in several animal species 
such as man (Arterberry et al., 1962), rat (Gaines, 1962; 
Michalek and Stavinoha, 1978), and sheep (Gopal et al., 
1976). In this study, however, the concurrent adminis-
® 
tration of phenothiazine anthelmintic with Ciovap sprays 
89 
did not potentiate the Ciovap® toxicity in the lambs (table 
12). Schlinke and Palmer (1973) also observed no poten-
tiation of toxicity when phenothiazine anthelmintic was 
used concurrently with a variety of organophosphorus insec-
ticide sprays in calves. Similarly, Malone (1962) found no 
potentiation in sheep when phenothiazine anthelmintic and 
organophosphorus pesticide combinations were administered 
orally. 
Phenothiazine anthelmintic treatments alone did not 
produce any observable adverse effects in A3 and a3 lambs 
over the period of the trial. This was not surprising 
since sheep are highly resistant to phenothiazine anthelmin-
tic toxicity (Clarke and Clarke, 1967; Buck et al., 1976a). 
Severe stress factors such as debilitating diseases and 
dehydration, however, may enhance the toxicity of pheno-
thiazine anthelmintic in sheep (Koch, 1963; Salisbury, 
1969; Salisbury et al., 1969). It is possible, therefore, 
that in this study the two lambs which died from the pheno-
thiazine treated groups A3 and a3 at the beginning of the 
experiment were under severe stress as judged by their 
extensive pleuropneurnonic conditions seen upon necropsy 
examination. 
Erythrocyte Cholinesterase (EChE) Activity: Signifi-
cant inhibition of EChE activity was an important feature of 
Ciovap® spray applications (figures 5, 6). There was no 
significant difference in the extent of EChE inhibition 
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between the parasitized and nonparasitized groups. This 
lack of differential effect may be due to the fact that the 
parasitized lambs were in good physical condition and did 
not show any of the adverse clinical effects associated with 
severe parasitism. Severe parasitism can stimulate malnu-
trition. Rats (Natoff, 1971) and sheep (Gopal et al., 1976) 
fed protein deficient diet were observed to be hyperreactive 
to organophosphorus toxicity. 
Concurrent phenothiazine administration did not poten-
® tiate the EChE inhibition caused by Ciovap applications. 
Furthermore, phenothiazine treatments alone did not inhibit 
EChE activity. These results are in agreement with previous 
reports concerning the nonpotentiating effect of phenothia-
zine anthelmintic in sheep and calves concurrently treated 
with organophosphorus insecticides (Malone, 1962; Schlinke 
and Palmer, 1973). 
Maximum inhibition of EChE activity occurred 24 hours 
® following each of the three Ciovap sprays. Significant 
recovery of the inhibited EChE activity occurred rapidly 
within 48 hours following the Ciovap® sprays. This period 
seemed to correspond to the time (2-3 days) required for 
the Ciovap® sprayed lambs to recover from clinical signs 
of Ciovap® toxicosis. Recovery of the inhibited EChE by 
organophosphorus compounds was reported to occur in two 
phases (Silvestri, 1975; Gopal ~al., 1976). A rapid 
recovery phase was shown to occur in a short period of 
time after exposure to the organophosphorus compound 
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because of the spontaneous hydrolysis of the enzyme~organo­
phosphorus complex. The prolonged recovery phase was 
attributed to the synthesis of new erythrocytes. This pro-
cess may last up to 120 days or more depending on the ex-
tent of enzymatic inhibition. In this experiment complete 
® 
recovery of pretreatment EChE levels of the Ciovap treated 
lambs was not attained during the posttreatment period 
which lasted only 30 days. 
Plasma Cholinesterase (PChE) Activity: During the 
trial, the PChE activities of all the control as well as 
all the treatment groups progressively decreased to levels 
below the pretreatment values (figures 9 and 10). Morizono 
and Kaba (1977) reported that storage of serum samples from 
cattle at -20°c for a 9 week period of time decreased serum 
ChE activity up to 5% (table 15). In this study the samples 
were stored at -4o0 c for 13 weeks or until they were assayed 
for the ChE activity. It is possible, however, that early 
experimental factors (e.g. initial stressors) and not stor-
age alone were causative in lowering the PChE activities of 
all the groups. It is therefore difficult to attribute the 
reduction of PChE activities of all the groups solely to 
the longer storage period used in this study. 
® Ciovap sprays significantly inhibited PChE activities 
of the parasitized A2 lambs, whereas those of the nonpara-
sitized B2 lambs were not significantly different from con-
trol values. This difference in susceptibility to the ChE 
TABLE 15 
REDUCTION IN SChE* ACTIVITY AFTER STORING AT LOW TEMPERATURES 
Storage 
Species Esterase Temp. 
Horse, SChE -20°c 
Dog 
Cattle, SChE -20°c 
Swine, Cat 
Horse SChE -17°c 
SChE -17°c 
* SChE - serum cholinesterase 
Duration 
of Storage 
9 weeks 
9 weeks 
8 weeks 
12 weeks 
% Redu,ct ion 
no change 
2-5% 
13% 
56% 
Reference 
Morizono and 
Kaba, 1977 
Schindler and 
Kruckenberg, 
1972 
\() 
N 
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® inhibitory action of Ciovap between A2 and B2 lambs could 
be due to the fact that A2 lambs were clinically parasi-
tized, although in good physical condition; and the disease 
condition enhanced the susceptibility of the animal to 
organophosphorus toxicity (Khan, 1973) • Group A1 and B1 
lambs which received both phenothiazine and Ciovap®, however, 
manifested significantly decreased PChE activities from 
respective control values. Concurrent phenothiazine treat-
ments did not potentiate PChE inhibition of A1 and B1 lambs, 
except after the second Ciovap spray when the PChE of A1 
lambs were significantly lower than those of A2 lambs. 
However, no significant differences were seen in the signs 
® 
of Ciovap toxicity between the A1 and A2 lambs. 
Relative to PChE activities of the control groups A4 
and B4 , the variations in the PChE activities of the pheno-
thiazine treated A3 and B3 lambs could not be attributed to 
phenothiazine treatment. 
Weight Gain: The phenothiazine treated groups A3 and 
B3 significantly gained more weight than did the other 
treatment and control groups (table 13). With the excep-
tion of groups A3 and B3 the remaining groups were similar 
in their weight gains. The significance of these obser-
vations are presently unknown. Increased weight gain and 
increased appetite, however, have been associated with the 
use of phenothiazine tranquilizers in man (Pfister, 1978; 
Mathues et al., 1959; Gordon, 1967; Byck, 1975). Varshney 
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and Singh (1976) found that the use of phenothiazine 
anthelmintic in growing lambs was associated with increased 
body weight gain. Similarly, Allen and Oldfield (1959) 
reporteu significant weight gain and improved carcass qual-
ity in parasitized lambs treated with phenothiazine anthel-
mintic. In contrast, Cauthen (1957) observed in one experi-
ment that moderately parasitized calves treated with various 
phenothiazine formulations for more than 121 days gained 
approximately 14% less weight than the parasitized untreated 
calves. However, when Cauthen (1952) fed small amounts of 
phenothiazine daily to parasitized cows for 3 consecutive 
years, he observed no significant differences in weight gain 
between treated and untreated groups. Other than a bene-
ficial antiparasitic effect of phenothiazine anthelmintic, 
it is difficult to postulate a mechanism for the increased 
weight gain of the phenothiazine treated animals. 
Total Plasma Protein (TPP) : During the trial para-
si tized A4 lambs manifested higher TPP levels than the 
nonparasitized B4 lambs. This difference could be due to 
the mildness of the parasitic infection of A4 lambs. The 
parasitized lambs in this study, however, were in good 
physical condition, and did not show any adverse clinical 
effects due to parasitism. Debilitated and chronically 
parasitized lambs, however, have been shown to manifest 
lower TPP levels (Sheriff and Habel, 1976). 
The pattern of fluctuatiosn of TPP levels associated 
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with the Ciovap , phenothiazine or Ciovap and phenothia-
zine treated groups could not be meaningfully interpreted 
although temporal significant changes were observed (fig-
ure 11). High doses of phenothiazine anthelmintic were 
reported to decrease serum albumin levels in cattle, espec-
ially in animals on low protein ration (Ross, 1959). Snow 
and Watson (1973) reported that dichlorvos increased TPP 
levels of the adult dog. In contrast no changes were seen 
in the TPP levels of puppies and cats treated with dichlor-
vos (Grey, 1974). Vorob'eva and Lapchenko (1973) observed 
that daily administration of crotoxyphos to dogs for 30 
days decreased serum albumin level and increased globulin 
level. Therefore, determination of the individual compon-
ents of the plasma proteins should clarify this aspect. 
Experiment II 
Thirty-two days following the third Ciovap® applica-
tion in experiment I, a challenge dose of Ciovap® (1 gallon 
of 0.25% emulsion) did not significantly increase the 
toxicosis more than that observed during experiment I. 
The EChE activities of Ciovap® sprayed lambs were 
significantly decreased. The extent of inhibition, however, 
was less than that observed after the third Ciovap® spray 
in experiment I. The time period allowed between the last 
Ciovap® application in experiment I and this experiment 
exceeded the 4 week period during which the Ciovap® exposed 
lambs allowed to recover from any drug induced adverse 
effects. The truism of this observation is emphasized by 
the fact that the EChE activities also recovered from the 
® 
severe inhibition seen after the last Ciovap spray in 
experiment I . The clinical significance of this observa-
tion is that a relatively longer unmedicated period (more 
® than 2 weeks) is needed between subsequent Ciovap appli-
cations. 
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Phenothiazine anthelmintic administration as a mixture 
in feed for 3 consecutive days did not potentiate Ciovap® 
toxicity, EChE or PChE inhibition. Phenothiazine treatment 
alone did produce any observable adverse effects in the 
treated lambs. 
Conclusions 
There was no apparent potentiation of Ciovap® toxicity 
in the lambs by concurrent phenothiazine anthelmintic 
administrations. 
Clinical parasitism with Haemonchus and Tricho-
strongylus species was not a factor in Ciovap® toxicity, 
since the parasitized lambs were in good physical con-
dition, and they did not show any observable adverse 
clinical effects associated with parasitism. 
A nonmedicated period of at least 2 weeks should be 
allowed between subsequent Ciovap® sprays because of the 
. ® increased inhibition of EChE activity after each Ciovap 
application. Erythrocyte cholinesterase activity was the 
best indicator of an animal's exposure to Ciovap®. 
Under field conditions phenothiazine anthelmintic 
treatment of gastrointestinal parasitic infection could 
be pr~cticed concurrently with topical application of 
organophosphorus insecticides to control external para-
sites. This is because of the economy and convenience 
of the practice. 
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VI. SUMMARY 
The temporal interaction of the organophosphorus insec-
ticide (Ciovap®) and phenothiazine anthelmintic was studied 
in 8 groups of 3 lambs, clinically free from or parasitized 
with Haemonchus and Trichostrongylus spp. In the first 
experiment each lamb in one of 3 parasitized groups and one 
of 3 nonparasitized groups was treated with phenothiazine 
orally (12.5 gm initially and 4 days later with 6.25 gm 
every 3 days for 9 treatments) , or Ciovap® dermally (1550 
ml of 0.25% emulsion sprayed every 2 weeks for 3 applica-
tions) or with both. Two groups served as controls. Onset 
of clinical signs, lethality, plasma cholinesterase (PChE) 
and erythrocyte cholinesterase (EChE) activities, and total 
plasma protein (TPP) levels were monitored. Following each 
Ciovap® spray signs of toxicity were seen within 40 minutes 
in both parasitized and nonparasitized lambs regardless of 
concurrent phenothiazine treatment. Phenothiazine alone 
was not toxic and did not inhibit PChE or EChE activities. 
EChE activities of Ciovap® sprayed lambs were significantly 
depressed regardless of parasitism or concurrent phenothia-
zine treatment. Transient but significant reduction of TPP 
levels occurred in the groups that just received Ciovap® . 
Thirty days following the last Ciovap® spray in experiment 
I, the same groups of lambs were used in experiment II and 
. ® 
were either sprayed with 1 gallon of 0.25% Ciovap emulsion 
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or treated orally with phenothiazine anthelmintic (54% 
active ingredient) 1 gm/lamb/day for 3 days mixed in the 
feed, or with both. Signs of toxicity were seen within 18 
® 
minutes in all the groups sprayed with Ciovap . Pheno-
thiazine alone was not toxic. Significant inhibition of 
® EChE and PChE activities occurred in the Ciovap treated 
groups. 
Data suggested no apparent potentiation of Ciovap® 
toxicity by concurrent phenothiazine anthelmintic treat-
ment. EChE inhibition was a better index of exposure to 
® Ciovap than PChE. 
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APPENDIX 
TABLE 16: PRE- AND POSTTREATMENTS ERYTHROCYTE CHOLINESTERASE ACTIVITY* (6pH/30 MIN) 
OF THE PARASITIZED (A) AND NONPARASITIZED (B) LAMBS. 
II of Ai Aa As A'- B1 Ba Bs B'-
Da~s CVE & Phetz CiovaE Phetz Control CvE & Phetz CiovaE Phetz Control 
-1 * 0. 7 2±0. 03 0.69±0.03 0.73±0.01 0.67±0.03 0.72±0.02 0.68±0.04 0.67±0.04 0.66±0.02 
a 0.64-0.80 0,61-0.79 0.69-0.76 0.57-0.76 0.68-0.77 0.57-0.80 0.53-0.76 0.59-0.70 
0 * 0. 71±0. 03 0.68±0.03 0.72±0.01 0.65±0.01 0. 72±0. 01 o. 70±0.03 0.69±0.04 0.65±0.02 
a 0 .63-0. 77 0.62-0.78 0.68-0.76 0.58-0.72 0.68-0.75 0.61-0.79 0.56-0.74 0.60-0. 70 
1 * 0.62±0.03 0,58±0.02 0.71±0.03 0.67±0.04 0.56±0.01 0.63±0.03 0.66±0.04 0.66±0.02 
a 0.55-0.69 0.50-0.65 0.62.:.0.76 0.56-0.79 0.50-0.59 0.55-0. 70 0.52-0.73 0.61-0.70 
2 * 0.55±0.03 0.53±0.02 0.68±0.04 0.66±0.03 0.54±0.02 0.57±0.03 0.66±0.04 0.65±0.02 
a 0.48-0.67 0.49-0.60 0.61-0.86 0.60-0.75 0.50-0.58 0.50-0.65 0.54-0.75 o. 58-0. 71 
3 * 0 .58±0.03 0.57±0.01 0.65±0.05 0.66±0.02 0.59±0.02 0.58±0.03 0.64±0.04 0.63±0.02 
a 0.51-0.66 0.54-0.60 0.56-0.87 0.58-0.73 0.54-0.68 0.50-0.66 0.52-0.74 0.55-0.67 
4 * 0.62±0.03 0 .61±0.03 0.66±0.02 0.67±0.05 0.59±0.04 0. 59±0 .04 0.65±0.05 0.64±0.02 
a 0.53-0. 70 0,56-0.70 0.61-0.70 0.49-0.78 0.54-0.73 0.50-0.69 0.50-0. 77 0.53-0.69 
6 * 0.61±0.04 0.60±0.03 0.75±0.03 0.64±0.04 0.57±0.04 0.59±0.03 0.63±0.04 0.67±0.03 
a 0.50-0.71 0.53-0.67 0.66-0.81 0.56-0.77 0.45-0.67 0.53-0.72 0.52-0. 73 0.61-0. 76 
7 * 0.62±0.05 0.61±0.02 o. 71±0. 04 0.62±0.03 0.59±0.03 0.64±0.05 0.60±0.03 0.62±0.02 
a 0.48-0.75 0.53-0.67 0.60-0.82 0.51-0.66 0.52-0.72 0.51-0.82 0.51-0.67 0.54-0.66 
9 * 0.64±0.07 0.58±0.04 0.71±0 .04 0.66±0.04 0.59±0.04 0.63±0 .05 0.59±0 .03 0.61±0 .03 
a 0.43-0.80 0.44-0.66 0.62-0.81 0.54-0.76 0.50-0.74 0.52-0.78 0.52-0.66 0.52-0.67 
* 
...... 
Mean ±SEM of each group. ...... 
a l.O The range of each group. 
Cvp & Phetz = Ciovap and Phenothiazine Continued pg 1 of 4 
TABLE 16 pg 2 of 4 
# of Ai Aa A3 Ai. Bi Ba B3 Bi. 
Daxs CvE & Phetz CiovaE Phetz Control CvE & Phetz CiovaE Phetz Control 
10 * 0.66±0.03 0.60±0.01 0.69±0.03 0.67±0.02 0.62±0.04 0.67±0.07 0.67±0.07 0.60±0.04 
a 0.58-0.73 0.57-0.63 0.63-0. 77 0.61-0.73 0.52-0.76 0.53-0.87 0.50-0.81 0.48-0.67 
11 * 0.60±0.03 0.56±0.02 0.67±0.04 0.67±0.03 0.60±0.05 0.65±0.08 0.60±0.08 0.61±0.02 
a 0.52-0.69 0.52-0.62 0.58-0.76 0.60-0.75 0.44-0. 72 0.41-0.88 0.48-0.72 0.57-0.64 
13 * 0.60±0.03 0.57±0.02 0.69±0.04 0.65±0.04 0.54±0.04 0.62±0.06 0.63±0.05 0.62±0.02 
a 0.50-0.69 0.50-0.62 0.58-0.72 0.53-0.72 0.48-0.67 0.47-0.86 0.50-0.70 0.54-0.65 
14 * 0.61±0.04 0.56±0.03 0.71±0.04 0.61±0.03 0.54±0.04 0.55±0.06 0.59±0.05 0.54±0.03 
Cl 0.52-0.73 0.50-0.63 0.60-0.80 0.54-0. 70 0.42-0.62 0.43-0.76 0.44-0.69 0.46-0.61 
15 * 0.58±0.04 0.54±0.02 0.64±0.03 0.60±0.03 0.53±0.03 0.58±0.05 0.58±0.06 0.56±0.02 
a 0.48-0.68 0.50-0.58 0.58-0.71 0.51-0.66 0.48-0.62 0.46-0.77 0.42-0.70 0.52-0.63 
16 * 0.40±0.04 0.33±0.02 0.68±0.03 0.62±0.03 0.32±0.04 0.35±0.06 0.63±0.04 0.58±0.04 
a 0.27-0.48 0.30-0.37 0.61-0.74 0.52-0.70 0.20-0.40 0.20-0.52 0.55-0.71 0.48-0.72 
17 * 0.59±0.04 0.55±0.03 0.68±0.03 0.62±0.03 0.51±0.03 0.56±0.03 0.60±0.05 0.59±0.02 
a 0.47-0.73 0.50-0.65 0.59-0.75 0.53-0.66 0.43-0.61 0.50-0.68 0.47-0.68 0.54-0.63 
20 * 0.56±0.05 0.57±0.03 o. 70±0.05 0.59±0.02 0.52±0.03 0.59±0.05 0. 66±0. 03 0.57±0.01 
a 0.45-0.65 0.49-0.66 0.61-0.83 0.54-0.63 0.43-0.61 0.48-0. 75 0.57-0.69 0.53-0.62 
21 * 0.56±0.03 0.53±0.02 0.68±0.03 0.63±0.04 0.52±0.03 0.57±0.05 0.62±0.04 0.56±0.02 
a 0.49-0.68 0.47-0.60 o. 63-0. 76 0.51-0.74 0.44-0.60 0.46-0.76 0.51-0.67 0.50-0. 59 
22 * 0.58±0.03 0.55±0.03 0.69±0.03 0.60±0.03 0.51±0.03 0.59±0.06 0.60±0.03 0.58±0.03 
a 0.49-0.68 0.47-0.61 0.61-0.78 0.52-0.66 0.41-0.60 0.46-0.80 0.50-0.65 0.413-0.65 f-' N 
0 
23 * 0.55±0.04 0.53±0.02 0.63±0.04 0.62±0.04 0.53±0.02 0.58±0.05 0.61±0.07 0.58±0.02 
a 0.43-0.68 0.47-0.61 0.56-0.71 0.52-0.74 0.46-0.60 0.45-0.75 0 .41··0.69 o.50-0.62 
* a Mean ±SEM of each group; Range of each group; Cvp & Phetz • Ciovap & Phenothiazine 
TABLE 16 pg 3 of 4 
II of Ai Aa As A,. Bi Ba Bs B,. 
Dais CvE ~ Phetz CiovaE Phetz Control CvE & Phetz CiovaE Phetz Control 
24 * 0.59±0.04 0.53±0.01 0.65±0.04 0.62±0.02 0.51±0.03 0.58±0.06 0.64±0.06 0,56±0.03 
a 0.53-0. 71 0,50-0.56 0. 55-0. 73 0.56-0.66 0.42-0.56 o.46-o. 11 0.50-0. 70 0.49-0.64 
27 * 0.59±0.03 0,56±0.02 o. 72±0 .03 0.69±0.02 0.57±0.03 0.59±0.05 0.63±0.05 0.54±0.03 
a 0.50-0.67 0,51-0.61 0.65-0.79 0.65-0.74 0.48-0.66 0.47-0.78 0,51-0.13 0.44-0.62 
28 * 0.61±0.03 0.59±0.02 0.70±0.02 0.67±0.02 0.62±0.02 0.63±0.05 0.63±0.05 0.58±0.03 
a 0.53-0.70 0,53-0.62 0,66-0.73 0.65-0.73 0.59-0.68 0.50-0.80 0.50-0.72 0.50-0.63 
29 * 0.56±0.04 0.46±0.02 0.69±0,02 0.63±0.03 0.45±0 .04 0.56±0.06 0.60±0.04 0.56±0.04 
a 0.48-0.66 0,40-0.52 0.64-0. 73 0.52-0.70 0.37-0.60 0.40-0.72 0.49-0.69 0.44-0.65 
30 * 0.36±0.04 0.29±0,02 0.71±0.03 0.64±0.02 0.26±0.04 0.37±0.05 0.65±0.04 0.59±0.03 
a 0.24-0.43 0.21-0.33 0.67-0. 77 0.58-0. 72 0.18-0.35 0.25-0.51 0.51-0.12 0.51-0.69 
31 * 0.52±0.02 0.47±0.03 0.67±0.05 0.64±0.03 0.46±0.03 0.50±0.05 0.57±0.04 0.5l1±0.02 
a 0 .47.-0.57. 0.38-0.52 0.63-0.84 0.58-0.74 0.36-0.56 0.37-0.66 0.45-0.64 0.49-0.63 
34 * 0.52±0.04 0.47A0.02 0.68±0.04 0.64±0 . 02 0.48±0.02 0.53±0.05 0.58±0.04 0.53±0.02 
a 0.42-0,61 0.41-0.52 0.60-0.75 0.58-0.72 0.40-0.54 0.42-0.67 0.47-0.65 0,41-0.56 
37 * 0.57±0.03 0.51±0.03 0.66±0.03 0.61±0.03 0.50±0.04 0.55±0.05 0.64±0.05 0.55±0.03 
a 0.51-0.63 0.41-0.57 0.62-0.73 0.49-0.67 0.41-0.58 0.43-0.67 0.49-0.71 0.48-0.64 
41 * 0.61±0.02 0.55±0.02 0.69±0.02 0.66±0.03 0.49±0.05 0.57±0.05 0.65±0.06 0.57±0.03 
a 0.52-0,66 0.50-0.66 0.65-0.75 o. 55-0·. 74 0.40-0.59 o.45-o. 10 0.48-0.74 0,49-0,63 
44 * 0.63±0.03 0.54±0.03 o. 70±0.01 0.66±0.03 0.52±0.04 0.57±0.05 0.66±0.05 0.55±0.02 
a 0.52-0.67 0.48-0.60 0.67-0.73 0.55-0.75 0.43-0.61 0.46-0.70 0.52-0.13 0.49-0.62 ...... N 
...... 
48 * 0.63±0.03 0.58±0.02 0.68±0.02 0.65±0.03 0.55±0.02 0.60±0.04 0.68±0 .05 0.60±0.02 
a 0.50-0.68 0.53-0.64 0.64-0.73 0.54-0.69 0.51-0.58 0.47-0.71 0.52-0.75 0.53-0.66 
* a Mean ±SEM of each group; Range of each group; Cvp & Phetz • Ciovap and Phenothiazine 
TABLE 16 pg 4 of 4 
# of A1 Aa A, Ai. B1 Ba B, Bi. 
Daxs CvE & Phetz CiovaE Phetz Control CvE & Phetz CiovaE Phetz Control 
Sl * 0.61±0.04 O.S9±0.02 0.68±0.03 0.64±0.02 O.Sl±0.04 O.S6±0.0S 0.68±0.07 O.S9±0.02 
a 0.49-0.66 o.ss-o.63 0.63-0.76 O.S7-0.68 0.40-0.S8 0.4S-0.72 O.S3-0.81 o.ss-0.6S 
SS * O.S9±0.03 O.S0±0.02 0.61±0.04 O.S9±0.03 0.49±0.03 O.S4±0.04 0.64±0.02 O.SS±0.02 
a 0.49-0,64 0.4S-O.SS 0. S4-0. 71 0.49-0.6S 0.43-0.S7 0.42-0.64 O.S7-0.67 O.S0-0.60 
S8 * 0.60±0.03 O.Sl±0.02 0.60±0.02 0.60±0.03 O.Sl±0.01 O.S7±0.03 O.S9±0.0S O.S3±0.0l 
a 0.49-0.66 0.47-0.S8 O.SS-0.66 O.S0-0.6S 0.49-0.S4 0.49-0.67 0.46-0.67 0.49-0.SS 
63 * 0.52±0.03 0.4S±0.02 0.61±0.03 0.60±0.03 0.40±0.02 0.4S±0.04 O.S8±0.04 O.SS±0.03 
a 0.42-0.S8 0.40-0.48 O.S6-0.68 0.47-0.6S 0.36-0.44 0.33-0.S6 0.47-0.62 0.46-0.64 
6S * 0.47±0.03 0.44±0.02 O.SS±0.03 0.60±0.02 0.3S±0.02 0.33±0.04 O.S4±0.03 O.S7±0.03 
a 0.40-0,S7 0.37-0.48 O.S0-0.61 O.S4-0.66 0.30-0.40 0.24-0.44 0.48-0.63 O.S2-0.68 
80 * 0.66±0.0S O.S7±0.02 0.69±0.03 0.68±0.04 O.S3±0.03 O.S7±0.04 0.68±0.08 o. 61±0·.03 
a 0.48-0.74 0.48-0.60 0.64-0. 77 o. S4-0. 7 s 0.4S-O.S7 0.4S-0.69 0.4S-0.76 O.S2-0.66 
* a Mean ±SEM of each group; Range of each group; Cvp & Phetz • Ciovap and Phenothiazine 
TABLE 17: PRE- AND POSTTREATMENTS PLASMA CHOLINESTERASE ACTIVITY (tipH/30 MIN) 
OF THE PARASITIZED (A) AND NONPARASITIZED (B) LAMBS. 
II of Ai A2 As A,. Bi B2 Bs B,. 
Da~s Cv2 & Phetz Ciova2 Phetz Control Cv2 & Phetz Ciova2 Phetz Control 
-1 * 0.19±0.01 0,18±0.01 0.17±0.02 0.18±0.02 0.18±0.01 0.19±0.01 0.17±0.01 0.20±0.02 
CL 0,16-0,21 0.14-0.21 0.11-0.22 0.12-0.21 0.16-0.20 0.16-0.21 0.14-0.20 0.16-0.25 
0 * 0.13±0.02 0,10±0,02 0.12±0.02 0.14±0.02 0.12±0.01 0.14±0.02 0.13±0.01 0.14±0.02 
CL 0.08-0.18 0.09-0.18 0.08-0.18 0.09-0.18 0.09-0.15 0.10-0.18 0.09-0.17 0.10-0.18 
1 * 0.14±0.004 0,14±0.01 0.17±0.02 0.19±0.01 0.13±0.01 0.16±0.01 0.15±0.01 0.18±0.02 
CL 0.13-0,15 0.10-0.17 0.12-0.20 0.16-0.21 0.10-0.14 0.12-0.20 0.12±0.19 0.13-0.22 
2 * 0.11±0.01 0.09±0.005 0.15±0.01 0.17±0.01 0.12±0.01 0.15±0.01 0.15±0.01 0.15±0.01 
CL 0.09-0,14 o.os-0.11 0.10-0.17 0.13-0.20 0.09-0.14 0.12-0.17 0.12-0.20 0.14-0.19 
3 * 0.12±0.01 0,11±0,01 0.14±0,01 0.16±0.02 0.12±0.01 0.13±0.01 0.13±0.01 0.16±0.01 
CL 0,09-0,15 0.09-0.14 0.11-0.15 0.09-0.21 0.10-0.14 0.11-0.15 0.09-0.16 0.12-0.21 
4 * 0.12±0.01 0,12±0.01 0.14±0.01 0.17±0.01 0.11±0. 01 0.14±0.01 0.15±0.01 0.16±0.01 
CL 0.10-0.14 0.10-0.13 0.10-0.16 0.14-0.20 0.08-0.14 0.11-0.18 0.08-0.16 0.13-0.18 
6 * 0.12±0.005 0.13±0.004 0.16±0.01 0.15±0.02 0.16±0.01 0.12±0.01 0.13±0.01 0.15±0.01 
CL 0,10-0,13 0,12-0.14 0.13-0.18 0.09-0.18 0.13-0.17 0.10-0.14 0.08-0.14 0.11-0.18 
7 * 0.09±0.02 0.16±0.01 0.16±0.01 0.13±0.01 0.13±0.01 0.16±0.01 0.14±0.02 0.14±0.01 
CL 0.04-0,14 0.13-0.21 0.13-0.18 0.11-0.15 0.10-0.14 0.15-0.19 0.10-0.19 0.10-0.17 
9 * 0.12±0.01 0.10±0,01 0.12±0.02 0.11±0.01 0.10±0.01 0.13±0.01 0.12±0.004 0.08±0.01 
CL 0.10-0.13 0,08-0.14 0.06-0.16 0.09-0.13 0.08-0.13 0.11-0.15 0.12-0.13 0.07-0.09 
...... 
10 * 0.11±0.01 0.12±0.01 0.16±0.01 0.14±0.01 0.12±0. 01 0.14±0.004 0.11±0.02 0.13±0.01 N w 
CL 0,09-0.13 0.09-0.15 0.13-0.18 0.12-0.17 0.10-0.13 0.13-0.15 0.08-0.14 0.11-0.14 
* CL Mean ±SEM of each group; The range of each group; Cvp & Phetz = Ciovap and Phenothiazine 
Continued, pg 1 of 4 
TABLE 17 pg 2 of 4 
fl of Ai Aa As A,. B1 Ba Bs Bi. 
Dais CvE & Phetz CiovaE Phetz Control CvE & Phetz CiovaE Phetz Control 
11 * 0.10±0.01 0.12±0.02 0.13±0.01 0.12±0.01 0.11±0.01 0.10±0.01 0.10±0.005 0.13±0.005 
a 0.07-0.14 0.08-0.18 0.10-0.16 0.10-0.13 0.08-0.13 0.06-0.13 0.08-0.10 0.12-0.14 
13 * 0.12±0.01 0.09±0.01 0.09±0.01 0.08±0.01 0.09±0.01 0.09±0.01 0.09±0.01 0.08±0.01 
a 0.09-0.15 0.08-0.11 0.08-0.11 0.06-0.12 0.06-0.11 0.06-0.13 0.08-0.11 0.06-0.11 
14 * 0.09±0.01 0.07±0.004 0.09±0.01 0.08±0.01 0.07±0.004 0.09±0.01 0.07±0.01 0.07±0.003 
a 0.08-0.11 0.06-0.09 0.07-0.10 0.05-0.09 0.06-0.08 0.05-0.11 0.05-0.09 0.06-0.08 
15 * 0.05±0.01 0.08±0.01 0.06±0.01 0.08±0.01 0.06±0.03 0.05±0.004 0.07±0.003 0.08±0.01 
a 0,02-0.07 0.07-0.10 0.03-0.08 0.07-0.11 0.05-0.06 0.04-0.07 0.06-0.07 0.05-0.10 
16 * 0.03±0,004 0.06±0.02 0.09±0.02 0.08±0.01 0.05±0.005 0.08±0.004 0.04±0.01 0.06±0.01 
a 0.02-0,04 0.03-0.10 0.05-0.14 0.05-0.11 0.04-0.06 0.07-0.09 O,Ol-0.06 0.04-0.07 
17 * 0.07±0.01 0.07±0.005 0.10±0.01 0,06±0.01 0.04±0.01 0.06±0.004 0.07±0.005 0.06±0.01 
a 0,05-0.08 0.05-0.08 0.08-0.11 0.04-0.07 0.02-0.08 0.04-0.07 0.06-0.08 0.03-0.09 
20 * 0.06±0.01 0,07±0.005 0.09±0.01 0.08±0.005 0.05.±0.01 0.05.±0.003 0.06.±0.003 0.06±0.01 
a 0.04-0.07 0.06-0.09 0.06-0.10 0.06-0.09 0.02-0.07 0.04-0.06 0.05-0.07 0.04-0.09 
21 * 0.07±0.004 0.07±0.004 0.09±0.01 0.08±0.01 0.05±0.01 0.06±0.01 0.05±0.01 0.05±0.01 
a 0.06-0,08 0.07-0.09 0.07-0.12 0.05-0.11 0.03-0. 06 o. 04-0.08 0.03-0.06 0.04-0.07 
22 * 0.04±0.01 0.06±0.01 0.09±0.01 0.09±0.01 0.05.±0.004 0.05.±0.01 0.05.±0.01 0.07±0.01 
a 0.02-0.07 0,04-0.08 0.07-0.10 0.08-0.11 0.04-0.06 0.03-0.08 0.04-0.06 0.03-0.10 
23 * 0.04±0.01 0,06±0.01 0.08±0.01 0.05.±0.01 0.05±0.01 0.06±0.005 0.07±0.003 0.07±0.01 ..... l'\J 
a 0.02-0.07 0.04-0.07 0.07-0.10 0.04-0.07 0.03±0.07 0.05-0.08 0.06-0.07 0.05-0.09 ~ 
* a Mean ±SEM of each group; The range of each group; Cvp & Phetz • Ciovap and Phenothiazine 
TABLE 17 pg 3 of 4 
# of Ai Aa As A,. Bi B2 Bs B,. 
Da~s Cv2 & Phetz CiovaE Phetz Control CVE & Phetz CiovaE Phetz Control 
24 * 0.08±0.01 0. 07±0.01 0.07±0.01 0.07±0.002 0.05±0.004 0.09±0.01 0.08±0.01 0.08±0.01 
a 0.05-0.09 0,04-0.09 0.04-0.09 0.06-0.07 0.04-0.06 0.07-0.11 0.06-0.10 0.05-0.11 
27 * 0 . 08±0.004 0.08±0,01 0.08±0,01 0.06±0.01 0.06±0.01 0.07±0.01 0.07±0.01 0.08±0.01 
a 0.07-0,09 0,06-0.10 0.06-0.09 0.05-0.08 0.04-0.08 0.05-0.10 0.04-0.09 0.05-0.11 
28 * 0.08±0.01 0.09±0.01 0.08±0.01 0.07±0.004 0.06±0.004 0.07±0.01 0.09±0.005 0.08±0.01 
a 0.07-0.10 0.07-0.10 0.06-0.09 0.06-0.08 0.05-0.07 0.05-0.10 0.08-0.10 0.06-0.10 
29 * 0.05±0.01 0.04±0.01 0.08±0.01 0.08±0.01 0.05±0.01 0.06±0.01 0.08±0.01 0.08±0.004 
a 0.04-0.07 0.02-0.06 0.05-0.10 0.06-0.09 0.03-0.06 0.04-0.07 0.06-0.09 0.07-0.09 
30 * 0.03±0.01 0.04±0.01 0.07±0.01 0.07±0.01 0.03±0.01 0.05±0.01 0.08±0.01 0.07±0.01 
a 0.02-0.05 0.03-0.06 0.05-0.08 0.04-0.09 0.00-0.05 0.02-0.07 0.05-0.10 0.04-0.10 
31 * 0.04±0.01 0.06±0.01 0.07±0.01 0.05±0.01 0.05±0.01 0.05±0.01 0.05±0.01 0.06±0.003 
a 0.02-0.07 0.03-0.08 0.06-0.09 0.02-0.08 0.00-0.08 0.02-0.08 0.04-0.07 0.06-0.07 
34 * 0.06±0.01 0.07±0.002 0.07±0.01 0.07±0.002 0.05±0.01 0.06±0.01 0.08±0.01 0.09±0.01 
a 0.04-0.07 0.06-0.07 0.06-0.08 0.06-0.07 0.02-0.05 0.04-0.08 0.06-0.10 0.07-0.12 
37 * 0.07±0.01 0.07±0.01 0.07±0.004 0.07±0.004 0.06±0.01 0.08±0.01 0.07±0.004 0.07±0.01 
a 0.05-0.08 0,06-0.09 0.06-0.08 0.06-0.08 0.05-0.09 0.06-0.10 0.06-0.08 0.06-0.09 
41 * 0 .07±0 .004 0.07±0.01 0.08±0.01 0.08±0.01 0.07±0.01 0.07±0.01 0.07±0.01 0.10±0.01 
a 0.06-0.08 0,06-0.10 0.05-0.09 0.06-0.10 0.05-0.09 0.05-0.10 o.o5-0.08 0.09-0.12 
44 * 0.06±0.01 0.06±0.005 0.07±0.004 0.07±0.004 0.08±0.01 0.08±0.01 0.07±0.005 0.08±0.01 
...... 
a 0.05-0.08 0.05-0.01 0.06-0.08 0.06-0.08 0.06-0.09 0.06-0.10 0.06-0.08 0.06-0.11 l'V 
* 
U1 a Mean ±SEM of each group; The range of each group; Cvp & Phetz = Ciovap and Phenothiazine 
TABLE 17 pg 4 of 4 
II of A1 Az As Ai. B1 Bz Bs Bi. 
Days Cvp & Phetz Ciovap Phetz Control Cvp & Phetz Ciovap Phetz Control 
48 * 0.08±0,01 0.08±0,01 0.09±0.005 0.09±0.01 0.09±0,003 0.08±0.01 0.08±0.005 0.08±0.01. 
a 0.07-0.10 0.01-0.10 0.08-0.10 0.01-0.10 0.09-0.10 0.05-0.10 0.01-0.09 0.06-0.10 
51 * 0.08±0.01 0.07±0.01 0.08±0.003 0.09±0.01 0.06±0.01 0.07±0.01 0.05±0.01 0.07±0.01 
a 0.05-0.13 0,06-0.08 0.01-0.08 0.01-0.11 0.04-0.08 0.05-0.09 0.03-0.08 0.05-0.08 
55 * 0.07±0.01 0.07±0,01 0.08±0,01 0.07±0.004 0.06±0.01 0.07±0.004 0.07±0.01 0.07±0.01 
a 0.05-0.10 0.05-0.09 0.06-0.10 0.06-0.08 0.05-0.08 0.06-0.08 0.04-0.08 0.05-0.09 
58 * 0.08±0.01 0.06 0.01 0.06 0.003 0,06±0.04 0.06±0.005 0.05±0.01 0.07±0.01 0.07±0.01 
a 0.06-0,10 0.05-0.08 0.05-0.07 0.05-0.08 0.05-0.07 0.03-0.08 0.04-0.08 0.06-0.10 
63 * 0.06±0.01 0.06±0,01 0.06±0.01 0.06±0.002 0.05±0.01 0.06±0.01 0.09±0.01 0.08±0.003 
a 0.02-0,09 0.05-0.07 0.04-0.07 0,05-0.06 0.02-0.06 0.04-0.08 0.07-0.11 0.07-0.09 
65 * 0.06±0.01 0.04±0.003 0.08±0.01 0.07±0.01 0.02±0.01 0.04±0.01 0.04±0.01 0.06±0.01 
a 0.04-0.08 0.04-0.05 0.06-0.09 0.06-0.09 0.00-0.04 0.02-0.06 0.02-0.05 0.04-0.09 
8 0 * 0. 08±0. 004 0.08±0.01 0.09±0.002 0.08±0.01 0.07±0.01 0.07±0.01 0.06±0.01 0.07±0.01 
a 0.07-0,09 0,06-0.10 0.07-0.08 0.06-0.09 0.06-0.08 0.06-0.09 0.04-0.07 0.05-0.09 
* a Mean ±SEM of each group; The range of each group; Cvp & Phetz • Ciovap and Phenothiazine 
TABLE 18 PRE- AND POSTTREATMENTS TOTAL PLASMA PROTEIN CONCENTRATIONS 
(gm/dl) OF THE PARASITIZED(A) AND NONPARASITIZED(B) LAMBS 
II of Ai Aa As A,. Bi Ba Bs B,. 
Daxs Cv2 & Phetz Ciova2 Phetz Control Cv2 & Phetz Ciova2 Phetz Control 
-1 * 8.3±0.3 8.0±0.3 8.2±0.3 8.2±0.3 8.0±0.2 7.7±0.2 7.8±0.4 8.3±0.1 
a 7.5-8.7 7 .1-8.5 7.9-8.7 7.1-8.9 7.5-8.5 7.3-8.1 7.1-8.9 7.9-8.7 
0 * 8.5±0.3 8.5±0.1 8.0±0.1 8.6±0.3 8.6 ±0.3 8.5±0.1 8.3±0.3 8. 6±0. 2 
a 8.2-9.7 8.4-8.8 7.9-8.3 8.2-8.9 7.7-9.3 8.4-8.8 7 .8-9.1 8.2-8.9 
1 * 8,6±0.3 7.8±0.2 7.7±0.1 8.0±0.2 8 .0±0.2 7.6±0.3 8 .1±0. 3 8,0±0.2 
a 7. 9-9. 4 7.1-8.3 7.5-7.9 7 .4-8.3 7.5-8.5 6.7-8.1 7. 7-9.1 7.7-8.4 
2 * 8 .0±0 .1 8.3±0.1 7.8±0.2 8.5±0.1 8.3±0.3 7.5±0.2 8.1±0.3 7.7±0.1 
a 7. 8-8. 2 7.9-8.5 7.5-8.2 8. 2-9.0 7. 9-9.1 6.6-8.0 7 .5-8.5 7.4-8.1 
3 * 8.2±0.2 8.4±0.1 7.7±0,2 8.6±0.3 8.3±0.4 7.4±0.3 8,0±0.2 7.9±0.1 
a 7.7-8.7 8,1-8.5 7 .3-8.0 8.0-9.3 7.9-9.0 6.9-7.9 7 .4-8.6 6.5-8.3 
4 * 8.3±0.2 8.4±0.1 8.0±0.2 8.6±0.2 8.1±0.2 7.5±0.2 7.7±0.2 8.0±0.1 
a 7. 9-8. 7 8.1-8.9 7.5-8.3 8.1-9.3 7 .8-9 .1 7. 0-8.0 7.4-8.2 7.8-8.3 
6 * 8.4±0.1 8,6±0.2 7.8±0.1 8.6±0.2 7.9±0.5 7.6±0.2 7.8±0.4 7. 6±0. 2 
a 8. 2-8. 7 8.0-9.3 7.5-8.1 8.2-9.3 6. 9-9. 9 6.9-8.1 6.6-8.5 6,9-8.1 
7 * 8.4±0.1 8.6±0.1 7.9±0.3 8.1±0.2 8.9±0.3 7.9±0.2 8.1±0.2 7.4±0.3 
a 8.3-8.7 8.3-8.9 7.3-8.5 7.5-8.5 8.3-9. 9 7 .3-8.5 7.4-8.5 6.3-7.9 
9 * 8.1±0.2 9.3±0,2 8.2±0.2 8,4±0.2 7.9±0.2 7.7±0.1 8.1±0.2 7.8±0.1 
a 7.5-8.7 7. 9-8. 7 7.7-8.5 8.1-8.9 7.4-8.5 7 .4-8.1 7.7-8.7 7.5-8.2 
...... 
10 * 8.1±0.2 8. 2±0. 2 8.1±0.1 8.1±0.1 8.3±0.2 7.3±0.3 8. 5±0. 2 7.8±0.2 N 
-....J 
a 7.7-8.7 7.7-8.5 7.8-8.3 7.7-8.3 7.9-9.3 6.3-7.9 8.0-9.1 7.5-8.7 
* a Mean ±SEM of each group; The range of each group; Cvp & Phetz a Ciovap and Phenothiazinc 
Continued pg 1 of 4 
TABLE 18 pg 2 of 4 
II of Ai Aa As A" Bi Ba Bs B" 
Days Cvp & Phetz Ciovap Phetz Control Cvp & Phetz Ciovap Phetz Control 
11 * 8,2±0,2 8,2±0,l 7.9±0.1 8.0±0.1 8.4±0.2 7.6±0.1 8,2±0.1 7.8±0.2 
a 7. 8-8. 7 7.9-8,3 7.7-8.1 7.7-8.3 7.9-9.2 7.3-8.0 7.8-8.5 7.4-8.5 
13 * 8.7±0.4 8.6±0.1 8,4±0.05 8.8±0.2 8.5±0.3 7.7±0.2 8.4±0.2 8.1±0.1 
a 7. 9-9 .1 8. 4-9. 0 8.3-8.5 8.3-9. 3 7.9-9.7 7 .3-8.3 8.1-8.9 8 .0-8.3 
14 * 7.8±0.2 7.8±0.05 7.4±0.1 7.9±0.1 8.2±0.3 7.6±0.2 7.7±0.2 7.1±0.1 
a 7.1-8.1 7. 7-7. 9 7.2-7.7 7.5-8.1 7 .3-9.3 7.2-8.3 7.4-8.3 6. 7-7 .4 
15 * 7.3±0.2 7.7±0,l 7.4±0.1 8,2±0.1 8.1±0.2 7.3±0.1 7.8±0.2 7.3±0.1 
a 6.8-7.8 7.5-8.1 7 .1-7. 8 7.7-B.5 7.4-8.7 7 .1-7 .8 7.5-8.4 7 .0-1. 5 
16 * 7.7±0.2 8.4±0.2 7.7±0.1 8.3±0.2 7.9±0.3 7.2±0.1 7.6±0.1 7.5±0.1 
a 7.1-8.2 8.0-9.1 7 .5-8.0 7.7-8.7 7.2-8.9 6.9-7.6 7.3-7.9 7.3-7.7 
17 * 7.6±0.2 7.8±0,l 7.7±0.2 8.0±0.2 7.8±0.1 7.4±0.1 7.5±0.1 7.5±0.1 
a 7. 0-8.3 7 .5-6.3 7.4-6.1 7.6-6.6 7 .1-6.1 7. 0-7. 7 7.5-7.7 7.3-7.7 
20 * 7.3±0.2 7.6±0.1 7.7±0.1 8.1±0.1 7.8±0.2 7.2±0.2 7.7±0.1 7.3±0.1 
a 6.6-7.9 7.5-8.1 7. 3-7. 9 7 .8-8.5 7.2-8.5 6. 7-7. 5 7.4-7.9 7 .1-7. 5 
21 * 7.6±0.3 7.6±0.1 7.8±0.2 7.8±0.1 7.7±0.2 7.1±0.1 7.5±0.1 7.4±0.1 
a 6 .8-8.3 7 .5-6. 3 7.4-6.2 7. 5-6.3 7 ,3-6.3 6.9-7.2 7 .3-7. 7 7. 2-7. 6 
22 * 7.8±0,2 8.0±0.1 7. 7±0.1 8.1±0.1 8.0±0.2 7.3±0.1 7.9±0.1 7.5±0.1 
a 7.1-8.3 7.7-6.3 7.5-S.O 7.7-S.5 7.6 8'.5 7 .1-7. 5 7.7-S.O 7,3-7,7 
I-' 
N 
23 * 7.7±0.3 8.0±0.1 7.8±0.2 8.2±0.2 8.3±0.2 7,3±0.2 8.1±0.1 7.5±0.1 a:> 
a 6.9-8.5 7.9-8.3 7.5-8.0 7.9-8.9 7.7-8.8 6. 9-7 ,8 7.9-8.4 7 .3-7. 7 
* a Mean ±SEM of each group; The range of each group; Cvp & Phetz a Ciovap and Phenothiazine 
TABLE 18 pg 3 of 4 
of Ai Aa As A,. B1 Ba Bs B,. 
Da~s CvE & Phetz Ciova2 Phetz Control Cv2 & Phetz Ciova2 Phetz Control 
24 * 7.7±0.2 8.0±0.2 7.6±0.2 7.9±0.2 8.3±0.3 7.3±0.1 7.9±0.2 7.9±0.1 
a 7.1-8.2 7.6-8.5 7 .3-8.1 7.6-8.6 7.4-9.0 1.1-1.5 1. 5-8.3 1. 1-8. 2 
27 * 7.5±0.2 7.8±0.1 7.7±0.2 8.4±0.2 8.1±0. 2 7.3±0.1 7.7±0.2 7.5±0.1 
a 7.1-7.9 7.5-8.1 7.4-8.1 8.0-9.1 7.7-8.8 1.0-1.5 7.5-7.9 7.3-7.7 
28 * 7.5±0.2 7.9±0.1 7.8±0.2 8.3±0.2 8.1±0.2 7.3±0.1 7.7±0.1 7.4±0.1 
a 7.1-7.9 7.4-8.2 7.5-8.2 7.9-9.2 7.8-8.8 7.1-7.6 7.4-8.0 1.2-1.6 
29 * 7.5±0.2 7.9±0.1 7.8±0.1 8.3 0.3 8.2±0.2 7.3±0.1 7.8±0.2 7.3±0.1 
a 6.9-8.0 7.5-8.3 7.6-8.1 7.7-9.3 7.8-8.9 7.1-7.6 7.3-8.2 7.1-7.7 
30 * 7.3±0.2 8.0±0.1 7.9±0.1 8.0±0.2 7.9±0.2 7.1±0.1 7.8±0.1 7. 7±0. 2 
a 6.8-7.7 7.7-8.5 7.7-8.1 7.5-8.9 7 .5-8. 5 6.9-7.4 7.5-8.0 7.1-8.3 
31 * 7.7±0.2 8.3±0.2 7.8±0.1 8.3±0.3 8.1±0.1 7. 2:?:0 .1 7.8±0.1 7.6±0.1 
a 7.1-8.3 7.8-8.8 7.7-8.1 7.5-9.3 7.7-8.5 7.1-7.5 7.4-8.0 7.2-7.8 
34 * 7.6±0.2 8.1±0.2 8.0±0.2 8.5±0.2 8.4±0.4 7.3±0.1 7.7±0.2 7.6±0.1 
a 7.1-7.9 7.5-8.8 7.5-8.3 8.1-9.1 7.7-9.7 6.9-7.7 7.3-8.2 7.4-8.0 
37 * 8.1±0.1 8.1±0.1 8.0±0.2 8.0±0.3 8.1±0.2 7.2±0.2 7.9±0.1 7.3±0.1 
a 7.9-8.3 7.8-8.3 7.4-8.5 7.6-9.2 7.6-8.4 6.8-7.6 7.5-8.1 7.1-7.7 
41 * 7.7±0.3 8.2±0.2 7.5±0.3 8.1±0.2 8.1±0.1 7.3±0.1 7.8±0.2 7. 7±0.1 
a 6.8-8.5 7.6-8.6 6.8-8.0 7.6-8.5 7.8-8.3 7.1-7.7 7.5-8.3 7.5-7.8 
44 * 
...... 
7.5±0.2 7.9±0.1 7.4±0.1 7.7±0.2 7.HO.l 7.2±0.2 7.3±0.1 7.2±0.1 N 
7.0-8.1 7.7-8.2 7.1-7.6 7.3-8.3 7.5-8.1 6.8-7.8 7.1-7.7 6.9-7.3 l.O a 
* a Mean ±SEM of each group; The range of each group; Cvp & Phetz • Ciovap and Phenothiazine 
TABLE 18 pg 4 of 4 
fl of Ai A:z As A,. 
Days Cvp & Phetz Ciovap Phetz Control 
48 * 7.9±0.3 8. 0±0.1 7. 5±0.1 8.0±0.1 
a 7.1-8.5 7.8-8.3 7. 3-7 .8 7.6-8.3 
51 * 7. 8±0.1 8.1±0.1 7.8±0.2 7. 9±0.1 
a 7.5-8.1 7. 9-8.3 7.3-8.2 7.7-8.3 
55 * 7. 7± o. 2 8.1±0.1 7.6±0.2 8.1±0.2 
a 7.1-8.1 7.9-8.4 7.5-8.3 7.9-8.7 
58 * 8.1±0.2 8.2±0.1 7.6±0.2 8.1±0.1 
a 7 .4-8. 7 7.9-8.3 7.3-8.2 7.9-8.3 
63 * 8.2±0.3 8.5±0.1 8.0±0.04 8.9±0.3 
a 7.6-9.3 8.3-8.8 7.9-8.1 8.2-9.7 
65 * 7.9±0.2 8.3±0.1 7 .8±0.1 8.4±0.3 
ex 7.1-8.2 7.9-8.8 7. 6-8. 2 7.8-9.1 
80 * 8.Cl!:0.2 8.1±0.1 8.2±0.2 8.1±0.1 
ex 7.5-8.7 7.9-8.5 7 .8-8.8 7.8-8.5 
* 
ex Mean ±SEM of each group; The range of each group; Cvp 
Bi B:z Bs 
Cvp & Phetz Ciovap Phetz 
8.2±0.03 7.7±0.2 8.1±0.2 
8.1-8.3 7.3-8.2 7.7-8.7 
7. 9±0.1 7. 4±0.1 7 .8±0.1 
7.8-8.1 7.1-7.7 7.4-8.1 
8.lliO.l 7.3:!:0.l 8.0±0.1 
7.9-8.1 7 .1-7. 5 7.7-8.3 
8.2±0.l 7.8±0.1 8.3±0.1 
7.9-8.6 7.6-7.9 7 .9-8.5 
8. 7± 0.3 7.9±0.2 9.0±0.3 
8.1-9.7 7 .5-8. 7 8.4-9.4 
8.3±0. 2 7. 7±0. 2 7. 7±0.1 
8.<r8.8 7. 3-8.4 7.5-7.9 
8.2±0.2 7.5±0.2 8.0±0.2 
7. 8-8.6 7.1-8.0 7 .6-8.5 
& Phetz ~ Ciovap and Phenothiazine 
B,. 
Control 
7.4±0.04 
7. 3-7. 5 
7.2±0. 1 
6. 9-7 .4 
7.5±0.1 
7.3-7.8 
7.5±0.2 
7.2-8.1 
7. 7± 0.1 
7.5-7.8 
7.6±0.1 
7. 4-7. 9 
7.6±0.1 
7 .3-7 .8 
I-' 
w 
0 
TABLE 19 
MEAN ±SEM WEIGHT GAIN OF THE LAMBS 
IN 65 DAYS (EXPERIMENT I) 
Group 
Clinical Parasitism 
Mean Weight Gain (lb) 
3.7±1.5 
(-2 - 6.5)* 
5.4±1.9 
(-1 - 9.5) 
14.4±5.0 
(3.5 - 25) 
7.1±2.7 
(2 - 16.5) 
No Clinical Parasitism 
* 
5. 6± 1. 4 
( 2 - 8) 
5. 5± 1.1 
(3 - 9) 
15.0±3.9 
(3.5 - 21) 
4.6±0.8 
(2.5 - 6.5) 
The range is shown in parenthesis. 
131 
MU Libraries  
University of Missouri--Columbia 
 
Digitization Information 
 
 
Local identifier   Mohammad1981 
 
Source information 
 
  Identifier   FILM T1981 -198 
  Format    Microfilm; filmed with others 
  Content type   Text, photographs 
  Notes      
    
 
Capture information 
 
  Date captured   2017 July 
  
  Scanner model   ScanPro 3000 
  Scanning software  PowerScan 3000™ Ver.5.309 
  Optical resolution  600 dpi, LZW compression 
  Color settings     grayscale 
  File types   tiff 
  Notes     
 
 
 
Derivatives - Access copy 
 
  Compression    
  Editing software  Adobe Acrobat XI  
  Resolution   600 dpi, LZW compression 
  Color    grayscale 
  File types   pdf 
  Notes    Page backgrounds lightened, text 
       darkened. Pages straightened. 
